BE FREE INC
8-K, 2000-03-14
COMPUTER PROCESSING & DATA PREPARATION
Previous: OMNINET INTERNATIONAL LTD, 20FR12G/A, 2000-03-14
Next: U S INTERACTIVE INC/PA, 8-K, 2000-03-14



<PAGE>

                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C.  20549

                                   FORM 8-K

                                CURRENT REPORT

                      PURSUANT TO SECTION 13 OR 15(D) OF

                      THE SECURITIES EXCHANGE ACT OF 1934

               Date of Report (Date of earliest event reported):

                      March 14, 2000 (February 29, 2000)
                      ----------------------------------


                                 BE FREE, INC.
            (Exact name of registrant as specified in its charter)


          Delaware                     000-27271                 04-3303188
       (State or other          (Commission File Number)       (IRS Employer
jurisdiction of incorporation)                               Identification No.)

                 154 Crane Meadow Road, Marlborough, MA 01752
            (Address of principal executive offices)     (Zip Code)

    Registrant's telephone number, including area code:   (508) 357-8888
                                                          --------------

                                Not Applicable
         (Former name or former address, if changed since last report)
<PAGE>

ITEM 2.  ACQUISITION OR DISPOSITION OF ASSETS

     On February 29, 2000, Be Free, Inc. (the "Company") completed its
acquisition of TriVida Corporation ("TriVida"), through the merger of Cyrano
Acquisition Corp., its wholly owned subsidiary, with and into TriVida (the
"Merger").  The Merger was pursuant to an Agreement and Plan of Merger, dated as
of February 15, 2000 (the "Merger Agreement") by and among the Company, Cyrano
Acquisition Corp. and TriVida.  The Merger Agreement is attached hereto as
Exhibit 2.
- ---------

     TriVida has developed personalization services for online merchants and
content sites.  These personalization services are designed to permit the
delivery of personalized promotions to unique users.

     On February 28, 2000, TriVida's shareholders approved the Merger.  No
approval by the Company's stockholders was required.  The Boards of Directors of
each of the Company and TriVida approved the Merger and the Merger Agreement.

     The execution of the Merger Agreement was announced on February 16, 2000.

     As consideration for the Merger, the Company issued an aggregate of
2,933,276 shares of its common stock, par value $.01 per share ("Common Stock"),
in exchange for the outstanding shares of TriVida capital stock.  The Company
also assumed options to purchase an additional 566,592 shares of Common Stock
previously issued by TriVida to its employees.  Under the terms of the Merger
Agreement and TriVida's option plan, such options became exercisable for shares
of Common Stock based upon the conversion ratio for the outstanding shares of
TriVida common stock.  The terms of the Merger were based upon arms' length
negotiations between unaffiliated parties.  There were no material relationships
between the Company, TriVida or any of their respective affiliates, officers or
directors.  The Merger is to be accounted for as a purchase for accounting
purposes.

     On March 8, 2000, the Company effectuated a 2-for-1 common stock split in
the form of a stock dividend paid to record holders as of March 1, 2000.  The
foregoing share information is presented on a post-split basis.

ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS

         (a)  Financial Statements of Business Acquired.

              The required financial statements and reports are attached hereto
              as pages F-1 through F-16.

         (b)  Pro Forma Financial Information.

              The required pro forma financial information is attached hereto as
              pages F-17 through F-20.

                                       2
<PAGE>

         (c)  Exhibits

              Exhibit 2     Agreement and Plan of Merger, dated February 15,
                            2000 by and among Be Free, Inc., Cyrano Acquisition
                            Corp. and TriVida Corporation

              Exhibit 23    Consent of Ernst & Young LLP

                                       3
<PAGE>

                         REPORT OF INDEPENDENT AUDITORS

Board of Directors
TriVida Corporation (a Development Stage Company)

   We have audited the accompanying balance sheets of TriVida Corporation (a
Development Stage Company) as of March 31, 1998 and 1999, and the related
statements of operations, stockholders' equity (deficit) and cash flows for the
years ended March 31, 1998 and 1999, and for the period from January 7, 1997
(date of inception) to March 31, 1999. These financial statements are the
responsibility of the Company's management. Our responsibility is to express an
opinion on these financial statements based on our audits.

   We conducted our audits in accordance with auditing standards generally
accepted in the United States. Those standards require that we plan and perform
the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement. An audit includes examining, on a test
basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.

   In our opinion, the financial statements referred to above present fairly,
in all material respects, the financial position of TriVida Corporation (a
Development Stage Company) at March 31, 1998 and 1999, and the results of its
operations and its cash flows for the years ended March 31, 1998 and 1999, and
for the period from January 7, 1997 (date of inception) to March 31, 1999, in
conformity with accounting principles generally accepted in the United States.

   As discussed in Note 2 to the financial statements, the Company's recurring
losses from operations and net capital deficiency raise substantial doubt about
its ability to continue as a going concern. Management's plans as to these
matters are also described in Note 2. The financial statements do not include
any adjustments that might result from the outcome of this uncertainty.

/s/ Ernst & Young LLP

October 15, 1999
Los Angeles, California

                                      F-1
<PAGE>

                              TRIVIDA CORPORATION
                         (A Development Stage Company)

                                 BALANCE SHEETS

<TABLE>
<CAPTION>
                                                March 31,
                                         ------------------------  December 31,
                                            1998         1999          1999
                                                                   (Unaudited)
<S>                                      <C>          <C>          <C>
                ASSETS
Current assets:
 Cash and cash equivalents.............  $   107,010  $   539,894  $  1,308,291
 Prepaid expenses and other current
  assets...............................        1,471        8,958           --
                                         -----------  -----------  ------------
  Total current assets.................      108,481      548,852     1,308,291
Computers and equipment, net of
 accumulated depreciation of $90,516
 and $399,675 at March 31, 1998, and
 1999 respectively; and $706,795 at
 December 31, 1999.....................      595,998      404,058     2,059,545
Deposits...............................      139,518      141,125       185,451
                                         -----------  -----------  ------------
  Total assets.........................  $   843,997  $ 1,094,035  $  3,553,287
                                         ===========  ===========  ============
 LIABILITIES AND STOCKHOLDERS' EQUITY
               (DEFICIT)
Current liabilities:
 Accounts payable......................  $   100,629  $   174,431  $    387,156
 Accrued expenses......................       88,992       13,798        25,763
 Related party payable.................      173,333      333,332       373,333
 Credit line payable...................       42,825       99,825        99,825
 Current portion of capital lease
  obligation...........................      250,798      237,743       495,778
                                         -----------  -----------  ------------
  Total current liabilities............      656,577      859,129     1,381,855
Capital lease obligations, less current
 portion...............................      224,067       52,475       807,251
Convertible notes......................      580,355      741,600           --
Commitments
Stockholders' equity (deficit):
 Preferred Stock, liquidation
  preference of $0.60 per share,
  4,000,000 and 11,000,000 shares
  authorized, 3,898,810 and 10,723,694
  Series A Convertible shares issued
  and outstanding at March 31, 1998 and
  1999, respectively; 11,000,000 shares
  authorized, 10,723,694 Series A
  Convertible shares issued and
  outstanding at December 31, 1999.....    2,339,286    6,462,289     6,462,289
 Preferred Stock, liquidation
  preference of $0.81 per share,
  8,223,694 shares authorized,
  7,761,205 Series B Convertible shares
  issued and outstanding at December
  31, 1999.............................          --           --      6,356,576
 Common stock, no par value, 6,000,000
  and 16,000,000 shares authorized,
  3,000,000 and 3,226,750 shares issued
  and outstanding at March 31, 1998 and
  1999, respectively; 16,000,000
  authorized, 4,085,499 shares issued
  and outstanding at December 31, 1999.        6,320       20,725        75,470
 Additional paid-in capital on common
  stock................................      307,800      877,280     2,403,810
 Deferred compensation.................     (202,598)    (517,500)   (1,460,150)
 Deficit accumulated during the
  development stage....................   (3,067,810)  (7,401,963)  (12,473,814)
                                         -----------  -----------  ------------
  Total stockholders' equity (deficit).     (617,002)    (559,169)    1,364,181
                                         -----------  -----------  ------------
Total liabilities and shareholders'
 equity (deficit)......................  $   843,997  $ 1,094,035  $  3,553,287
                                         ===========  ===========  ============
</TABLE>

                            See accompanying notes.

                                      F-2
<PAGE>

                              TRIVIDA CORPORATION
                         (A Development Stage Company)

                            STATEMENTS OF OPERATIONS

<TABLE>
<CAPTION>
                                                                                                     Period from
                                                       Period from        Nine Months Ended        January 7, 1997
                          Year ended March 31,       January 7, 1997        December 31,         (date of inception)
                         ------------------------  (date of inception) ------------------------    to December 31,
                            1998         1999       to March 31, 1999     1998         1999             1999
                                                                             (Unaudited)             (Unaudited)
<S>                      <C>          <C>          <C>                 <C>          <C>          <C>
Revenues ............... $       --   $   119,750      $   119,750     $   119,750  $       --      $    119,750
Operating expenses:
  Sales and marketing ..     577,500      931,546        1,509,046         731,326    1,536,422        3,045,468
  Research and
   development .........     820,670    1,156,728        1,991,411         840,455    1,046,920        3,038,331
  General and
   administrative ......   1,409,399    1,993,764        3,569,143       1,465,177    1,966,474        5,535,617
  Amortization of
   deferred equity-based
   compensation.........      83,962      230,378          314,340         164,185      286,135          600,475
                         -----------  -----------      -----------     -----------  -----------     ------------
Loss from operations ...  (2,891,531)  (4,192,666)      (7,264,190)     (3,081,393)  (4,835,951)     (12,100,141)
Other income (expense):
  Interest income ......      35,199       38,974           74,173          35,316       57,658          131,831
  Interest expense .....     (29,885)    (179,661)        (209,546)       (131,511)    (292,758)        (502,304)
                         -----------  -----------      -----------     -----------  -----------     ------------
Total other income
 (expense) .............       5,314     (140,687)        (135,373)        (96,195)    (235,100)        (370,473)
                         -----------  -----------      -----------     -----------  -----------     ------------
Net loss before taxes ..  (2,886,217)  (4,333,353)      (7,399,563)     (3,177,588)  (5,071,051)     (12,470,614)
Taxes ..................        (800)        (800)          (2,400)           (800)        (800)          (3,200)
                         -----------  -----------      -----------     -----------  -----------     ------------
Net Loss ............... $(2,887,017) $(4,334,153)     $(7,401,963)    $(3,178,388) $(5,071,851)    $(12,473,814)
                         ===========  ===========      ===========     ===========  ===========     ============
</TABLE>


                            See accompanying notes.

                                      F-3
<PAGE>

                              TRIVIDA CORPORATION
                         (A Development Stage Company)

                 STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

<TABLE>
<CAPTION>
                      Preferred Stock      Preferred Stock                                                        Accumulated
                          Class A              Class B          Common Stock        Additional                   Deficit During
                   --------------------- -------------------- ----------------- Paid-in Capital on   Deferred     Development
                     Shares     Amount    Shares     Amount    Shares   Amount     Common Stock    Compensation      Stage
<S>                <C>        <C>        <C>       <C>        <C>       <C>     <C>                <C>           <C>
Balance at
January 7, 1997
(date of
inception).......         --  $      --        --  $      --        --  $   --      $      --      $       --     $        --
 Initial
 capitalization..         --         --        --         --  2,625,000   6,000            --              --              --
 Issuance of
 Series A
 Preferred Stock.   2,125,000  1,275,000       --         --        --      --             --              --              --
 Issuance of
 common stock....         --         --        --         --    375,000     320            --              --              --
 Net loss........         --         --        --         --        --      --             --              --         (180,793)
                   ---------- ---------- --------- ---------- --------- -------     ----------     -----------    ------------
Balance at March
31, 1997.........   2,125,000  1,275,000       --         --  3,000,000   6,320            --              --         (180,793)
 Issuance of
 Series A
 Preferred Stock.   1,773,810  1,064,286       --         --        --      --             --              --              --
 Stock options
 issued to
 consultants.....         --         --        --         --        --      --          21,240             --              --
 Stock option
 compensation....         --         --        --         --        --      --         286,560        (286,560)            --
 Amortization of
 deferred
 compensation....         --         --        --         --        --      --             --           83,962             --
 Net loss........         --         --        --         --        --      --             --              --       (2,887,017)
                   ---------- ---------- --------- ---------- --------- -------     ----------     -----------    ------------
Balance at March
31, 1998.........   3,898,810  2,339,286       --         --  3,000,000   6,320        307,800        (202,598)     (3,067,810)
 Issuance of
 Series A
 Preferred Stock
 (June 1998).....   1,805,506  1,083,304       --         --        --      --             --              --              --
 Conversion of
 Promissory Notes
 to Series A
 Preferred Stock
 (June 1998).....   1,550,592    950,032       --         --        --      --             --              --              --
 Issuance of
 common stock....         --         --        --         --    200,000  12,000            --              --              --
 Issuance of
 Series A
 Preferred Stock
 (August 1998)...     833,333    500,000       --         --        --      --             --              --              --
 Conversion of
 Promissory Notes
 to Series A
 Preferred Stock
 (December 1998).   1,305,140    783,079       --         --        --      --             --              --              --
 Stock options
 issued to
 consultants.....         --         --        --         --        --      --          24,200             --              --
 Conversion of
 Promissory Notes
 to Series A
 Preferred Stock
 (March 1999)....   1,330,313    798,188       --         --        --      --             --              --              --
 Issuance of
 stock purchase
 warrants........         --       8,400       --         --        --      --             --              --              --
 Exercise of
 stock options...         --         --        --         --     26,750   2,405            --              --              --
 Stock option
 compensation....         --         --        --         --        --      --         545,280        (545,280)            --
 Amortization of
 deferred
 compensation....         --         --        --         --        --      --             --          230,378             --
 Net loss........         --         --        --         --        --      --             --              --       (4,334,153)
                   ---------- ---------- --------- ---------- --------- -------     ----------     -----------    ------------
Balance at March
31, 1999.........  10,723,694 $6,462,289       --         --  3,226,750  20,725        877,280        (517,500)     (7,401,963)
 Issuance of
 Series B
 Preferred Stock
 (August 1999)
 (unaudited).....         --         --  5,670,818  4,593,362       --      --             --              --              --
 Conversion of
 promissory notes
 (August 1999)
 (unaudited).....         --         --  2,090,387  1,693,214       --      --             --              --              --
 Issuance of
 stock purchase
 warrants
 (unaudited).....         --         --        --      70,000       --      --         260,645             --              --
 Exercise of
 stock options
 (unaudited).....         --         --        --         --    858,749  54,745            --              --              --
 Stock options
 issued to
 consultants
 (unaudited).....         --         --        --         --        --      --          37,100             --              --
 Stock option
 compensation
 (unaudited).....         --         --        --         --        --      --       1,228,785      (1,228,785)            --
 Amortization of
 deferred
 compensation
 (unaudited).....         --         --        --         --        --      --             --          286,135             --
 Net loss
 (unaudited).....         --         --        --         --        --      --             --              --       (5,071,851)
                   ---------- ---------- --------- ---------- --------- -------     ----------     -----------    ------------
Balance at
December 31, 1999
(unaudited)......  10,723,694 $6,462,289 7,761,205 $6,356,576 4,085,499 $75,470     $2,403,810     $(1,460,150)   $(12,473,814)
                   ========== ========== ========= ========== ========= =======     ==========     ===========    ============
<CAPTION>
                     Total
<S>                <C>
Balance at
January 7, 1997
(date of
inception).......  $      --
 Initial
 capitalization..       6,000
 Issuance of
 Series A
 Preferred Stock.   1,275,000
 Issuance of
 common stock....         320
 Net loss........    (180,793)
                   -----------
Balance at March
31, 1997.........   1,100,527
 Issuance of
 Series A
 Preferred Stock.   1,064,286
 Stock options
 issued to
 consultants.....      21,240
 Stock option
 compensation....         --
 Amortization of
 deferred
 compensation....      83,962
 Net loss........  (2,887,017)
                   -----------
Balance at March
31, 1998.........    (617,002)
 Issuance of
 Series A
 Preferred Stock
 (June 1998).....   1,083,304
 Conversion of
 Promissory Notes
 to Series A
 Preferred Stock
 (June 1998).....     950,032
 Issuance of
 common stock....      12,000
 Issuance of
 Series A
 Preferred Stock
 (August 1998)...     500,000
 Conversion of
 Promissory Notes
 to Series A
 Preferred Stock
 (December 1998).     783,079
 Stock options
 issued to
 consultants.....      24,200
 Conversion of
 Promissory Notes
 to Series A
 Preferred Stock
 (March 1999)....     798,188
 Issuance of
 stock purchase
 warrants........       8,400
 Exercise of
 stock options...       2,405
 Stock option
 compensation....         --
 Amortization of
 deferred
 compensation....     230,378
 Net loss........  (4,334,153)
                   -----------
Balance at March
31, 1999.........    (559,169)
 Issuance of
 Series B
 Preferred Stock
 (August 1999)
 (unaudited).....   4,593,362
 Conversion of
 promissory notes
 (August 1999)
 (unaudited).....   1,693,214
 Issuance of
 stock purchase
 warrants
 (unaudited).....     330,645
 Exercise of
 stock options
 (unaudited).....      54,745
 Stock options
 issued to
 consultants
 (unaudited).....      37,100
 Stock option
 compensation
 (unaudited).....         --
 Amortization of
 deferred
 compensation
 (unaudited).....     286,135
 Net loss
 (unaudited).....  (5,071,851)
                   -----------
Balance at
December 31, 1999
(unaudited)......  $1,364,181
                   ===========
</TABLE>

                            See accompanying notes

                                      F-4
<PAGE>

                              TRIVIDA CORPORATION
                         (A Development Stage Company)

                            STATEMENTS OF CASH FLOWS

<TABLE>
<CAPTION>
                                                                                                      Period from
                                                        Period from        Nine months ended        January 7, 1997
                           Year ended March 31,       January 7, 1997        December 31,         (date of inception)
                          ------------------------  (date of inception) ------------------------    to December 31,
                             1998         1999       to March 31, 1999     1998         1999             1999
                                                                              (Unaudited)             (Unaudited)
<S>                       <C>          <C>          <C>                 <C>          <C>          <C>
Operating activities
 Net loss...............  $(2,887,017) $(4,334,153)     $(7,401,963)    $(3,178,388) $(5,071,851)    $(12,473,814)
 Adjustments to
  reconcile net loss to
  net cash used in
  operating activities:
 Depreciation...........       90,516      309,159          402,074         254,334      307,120          709,194
 Other common stock
  expense...............       21,240       24,200           45,440          24,200      297,745          343,185
 Interest converted to
  equity................          --       118,833          118,833          35,588       71,927          190,760
 Amortization of
  deferred equity-based
  compensation..........       83,962      230,378          314,340         164,185      286,135          600,475
 Changes in operating
  assets and
  liabilities:
  Prepaid expenses......       (1,471)      (7,487)          (8,958)        (88,400)       8,958              --
  Deposits..............     (137,668)      (1,607)        (141,125)         (4,107)      25,673         (115,452)
  Accounts payable......       29,510       73,802          174,431              34      212,725          387,156
  Accrued expenses......       88,992      (75,194)          13,798         (18,997)      11,966           25,764
  Related party payable.      160,000      159,999          333,332         120,000       40,001          373,333
                          -----------  -----------      -----------     -----------  -----------     ------------
Net cash used in
 operating activities...   (2,551,936)  (3,502,070)      (6,149,798)     (2,691,551)  (3,809,601)      (9,959,399)
Investing activities
Purchase of property and
 equipment..............      (98,330)     (40,548)        (171,774)        (56,704)    (694,360)        (866,134)
Proceeds from sales of
 equipment..............       30,497          --            30,497             --           --            30,497
                          -----------  -----------      -----------     -----------  -----------     ------------
Net cash used in
 investing activities...      (67,833)     (40,548)        (141,277)        (56,704)    (694,360)        (835,637)
Financing activities
Payments of capital
 lease obligations......     (113,319)    (261,318)        (374,637)       (195,639)    (255,435)        (630,072)
Credit line borrowings..       42,825       57,000           99,825          57,000          --            99,825
Issuance of Series A
 Preferred Stock........    1,064,286    1,583,304        3,922,590       1,583,304          --         3,922,590
Issuance of Series B
 Preferred Stock........          --           --               --              --     4,593,362        4,593,362
Issuance of common
 stock..................          --        14,405           20,725          14,000       54,745           75,470
Issuance of convertible
 promissory notes.......      580,355    2,582,111        3,162,466       1,832,111      879,687        4,042,153
                          -----------  -----------      -----------     -----------  -----------     ------------
Net cash provided by
 financing activities...    1,574,147    3,975,502        6,830,969       3,290,776    5,272,359       12,103,328
                          -----------  -----------      -----------     -----------  -----------     ------------
Net increase (decrease)
 in cash and cash
 equivalents............   (1,045,622)     432,884          539,894         542,521      768,398        1,308,292
Cash and cash
 equivalents, beginning
 of period..............    1,152,632      107,010              --          107,010      539,893          539,893
                          -----------  -----------      -----------     -----------  -----------     ------------
Cash and cash
 equivalents, end of
 period.................  $   107,010  $   539,894      $   539,894     $   649,531  $ 1,308,291     $  1,848,185
                          ===========  ===========      ===========     ===========  ===========     ============
Supplemental
 disclosures:
 Interest paid..........  $    23,562  $   166,307      $   189,869     $    19,585  $    73,026     $    262,895
                          ===========  ===========      ===========     ===========  ===========     ============
Supplemental disclosure
 of non-cash
 transactions:
 During the years ended March 31, 1998 and 1999, the Company entered into capital lease
  obligations totaling $588,184 and $76,671, respectively.
 During the year ended March 31, 1999, $2,412,466 in convertible notes and $118,833 in
  accrued interest were converted into 4,186,045 shares of Series A Preferred Stock.
 During the nine months ended December 31, 1998 and 1999, the Company entered into capital
  lease obligations totaling $64,863 and $1,268,242, respectively.
 During the nine months ended December 31, 1998, $1,697,593 in convertible notes and $35,588
  in accrued interest were converted into 1,330,313 shares of Series A Preferred Stock.
 During the nine months ended December 31, 1999, $1,621,287 in convertible notes and $71,927
  in accrued interest were converted into 2,090,387 shares of Series B Preferred Stock.
</TABLE>

                            See accompanying notes.

                                      F-5
<PAGE>

                              TRIVIDA CORPORATION
                         (A Development Stage Company)

                         NOTES TO FINANCIAL STATEMENTS
  (Information at December 31, 1999 and for the nine months ended December 31,
                          1998 and 1999 is unaudited)

1. Business Activity

   TriVida Corporation (the Company), formally Nemogen Corporation, was
incorporated on January 7, 1997, in California. The Company was formed to
develop and market transactional stream analysis software products. The Company
has changed its business model from transactional stream analysis software
products to networked website personalization. Website personalization allows
companies to customize sales and marketing information on their websites, in
hopes of increasing sales, by predicting customer preferences from comparing a
customer's selections to those made by other customers previously. The
Company's service is provided over the Internet, in real time. To date the
Company has devoted the majority of its efforts to product development
activities and the raising of capital. As such, the Company is considered to be
in the development stage at March 31, 1999.

2. Basis of Presentation and Summary of Significant Accounting Policies

Basis of Presentation

   The Company has experienced recurring operating losses and has a deficiency
in working capital and stockholders' equity. The Company's growth and product
development have required significant capital, which historically has been met
primarily through the sale of stock and the issuance of convertible promissory
notes. Management believes that additional capital will be needed to fund the
Company's ongoing product development and marketing efforts. Management
believes that the necessary capital to fund these efforts for the next twelve
months will be raised through the sale of additional shares of the Company's
Series B Preferred Stock or other securities of the Company. However, there can
be no assurance that such financing will be completed. Without additional
financing, the Company will be required to reduce its product development and
marketing efforts. These conditions raise substantial doubt about the Company's
ability to continue as a going concern.

   The accompanying financial statements have been prepared assuming that the
Company will continue as a going concern and do not include any adjustments to
reflect the net realizable value of the Company's net assets in the event that
the Company is unable to sustain its operations.

Unaudited Interim Results

   The accompanying balance sheet as of December 31, 1999, the statements of
operations and cash flows for the nine months ended December 31, 1998 and 1999
and the statement of stockholders' equity (deficit) for the nine months ended
December 31, 1999 are unaudited. The unaudited interim financial statements
have been prepared on the same basis as the annual financial statements and, in
the opinion of management, reflect all adjustments, which included only normal
recurring adjustments, necessary to present fairly the Company's financial
position, results of

                                      F-6
<PAGE>

                              TRIVIDA CORPORATION
                         (A Development Stage Company)

                   NOTES TO FINANCIAL STATEMENTS--(Continued)
           (Information at December 31, 1999 and for the nine months
                 ended December 31, 1998 and 1999 is unaudited)

operations and cash flows as of December 31, 1999 and for the nine months ended
December 31, 1998 and 1999. The financial data and other information disclosed
in these notes to the financial statements related to these periods are
unaudited.

Cash and Cash Equivalents

   Cash equivalents include highly liquid investments with maturities of three
months or less from the date of purchase.

Fair Value of Financial Instruments

   The carrying amount of cash and cash equivalents approximates fair value due
to the short maturities of those instruments. The carrying amount of the
Company's credit line payable approximates fair value due to its variable rate
nature. There is no established market for the Company's convertible promissory
notes; however, management believes that the carrying amount approximates fair
value.

Computers and Equipment

   Computers and equipment, including assets recorded under capital leases, are
stated at cost. These assets are depreciated using the straight-line method
over the estimated useful life of three years or over the period of the lease,
whichever is shorter.

Long-Lived Assets

   The Company accounts for long-lived assets in accordance with Statement of
Financial Accounting Standards No. 121, "Accounting for the Impairment of Long-
Lived Assets and for Long-Lived Assets to be Disposed Of." The Company reviews
for the impairment of long-lived assets and certain identifiable intangibles
whenever events or changes in circumstances indicate that the carrying amount
of an asset may not be recoverable. Under Statement No. 121, an impairment loss
would be recognized when estimated future cash flows expected to result from
the use of the asset and its eventual disposition is less than its carrying
amount. No such impairment losses have been identified by the Company.

Income Taxes

   The Company accounts for income taxes using the liability method, as
required by Statement of Financial Accounting Standards No. 109, "Accounting
for Income Taxes." Deferred tax assets and liabilities are determined based on
differences between financial reporting and tax bases of assets and
liabilities, and are measured using enacted tax rates and laws expected to be
in effect when the

                                      F-7
<PAGE>

                              TRIVIDA CORPORATION
                         (A Development Stage Company)

                   NOTES TO FINANCIAL STATEMENTS--(Continued)
           (Information at December 31, 1999 and for the nine months
                 ended December 31, 1998 and 1999 is unaudited)

differences are expected to reverse. Valuation allowances are established when
necessary to reduce the carrying amount of deferred tax assets to their net
realizable value.

Accounting for Stock Based Compensation

   The Company has elected to follow Accounting Principles Board Opinion No.
25, "Accounting for Stock Issued to Employees" (APB No. 25), and related
interpretations in accounting for its stock options as permitted under
Statement of Financial Accounting Standards No. 123, "Accounting for Stock-
Based Compensation" (SFAS No. 123). The required pro forma disclosure for
compensation expense under SFAS No. 123 are disclosed in Note 4.

Research and Development Costs

   Pursuant to the Statement of Financial Accounting Standards No. 86,
"Accounting for the Costs of Computer Software to be Sold, Leased, or Otherwise
Marketed," the Company is required to capitalize software development costs
when "technological feasibility" of the product has been established and
anticipated future revenues assure recovery of the capitalized amounts. Because
the Company's product is still in the development phase, software development
costs have been charged to product development expenses in the accompanying
statements of operations.

Estimates and Assumptions

   The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities in the
financial statements and the accompanying notes. Actual results could differ
from those estimates.

Reclassifications

   Certain prior year financial statement items have been reclassified to
conform to the current period's presentation.

3. Stockholders' Equity (Deficit) and Convertible Notes

   The Company was initially capitalized in January 1997, with the issue of
2,625,000 shares of common stock for a total of $6,000. On March 14, 1997, the
Company issued 2,125,000 shares of Series A Preferred Stock at a purchase price
of $0.60 per share to Woodside Fund III, L.P. (Woodside) and InnoCal L.P.
(InnoCal). The Company issued an additional 375,000 shares of common stock to
Woodside for a total of $320. An additional 1,773,810 shares of Series A
Preferred Stock at $0.60 per share were issued to Woodside and InnoCal and
certain other Series A Preferred Stockholders in August 1997.

                                      F-8
<PAGE>

                              TRIVIDA CORPORATION
                         (A Development Stage Company)

                   NOTES TO FINANCIAL STATEMENTS--(Continued)
           (Information at December 31, 1999 and for the nine months
                 ended December 31, 1998 and 1999 is unaudited)


   In February 1998, the Company issued to Woodside, Innocal and several
existing Series A Preferred shareholders convertible promissory note totaling
$580,355. The notes were non-interest bearing and payable upon demand of the
holders. In connection with the issuance of the convertible notes, warrants to
purchase common shares at $0.10 per share upon the closing of an equity
financing with proceeds of at least $5 million, were issued to Woodside and
InnoCal. The number of shares subject to the warrant will be equivalent to the
number of shares which would equal $75,000 of fair value of common stock at the
time of the financing, as determined by the Company's Board of Directors. These
warrants will expire in February 2004, to the extent not previously exercised.
As of March 31, 1999, such a financing has not occurred and no warrants have
been exercised. The conversion feature of the convertible promissory notes was
later amended to allow for conversion upon the next round of equity financing.

   In April, May and June 1998, the Company issued convertible promissory notes
to Woodside and InnoCal totaling $670,000. These notes bore an interest rate of
10% per annum and were due upon demand. These notes were convertible into
shares of the Company's Series A Preferred Stock at the option of the holder.

   In June 1998, the Company entered into a Series A Preferred Stock Agreement
whereby the Company issued 1,805,506 shares of Series A Preferred Stock at a
purchase price of $0.60 per shares. Concurrent with this equity financing,
$930,355 in outstanding convertible notes and $19,677 in accrued interest were
converted into 1,550,592 shares of the Company's Series A Preferred Stock.

   Also in June 1998, the Company issued additional convertible promissory
notes totaling $998,024 to Woodside, InnoCal and several other existing
shareholders. These notes bore an interest rate of 10% per annum and were due
upon demand. These notes were convertible into shares of the Company's Series A
Preferred Stock upon the next round of equity financing.

   On July 28, 1998, InnoCal purchased 200,000 shares of the Company's common
stock for $12,000.

   On July 31, 1998, the Company issued to idealab! Capital Partners I-A and I-
B, L.P. (idealab!) convertible promissory notes totaling $500,000 and bearing
an interest rate of 10% per annum. The unpaid balance and accrued interest on
the notes will be converted into shares of the Company's Series A Preferred
Stock at a rate of $0.60 per shares. Additionally, in August 1998, the Company
issued to idealab! 833,333 shares of Series A Preferred Stock for a price of
$0.60 per share.

   On December 31, 1998, pursuant to the provisions of the promissory note
agreements, $749,012 in outstanding convertible promissory notes, plus $34,067
in accrued interest were converted into 1,305,140 shares of the Company's
Series A Preferred Stock.


                                      F-9
<PAGE>

                              TRIVIDA CORPORATION
                         (A Development Stage Company)

                   NOTES TO FINANCIAL STATEMENTS--(Continued)
           (Information at December 31, 1999 and for the nine months
                 ended December 31, 1998 and 1999 is unaudited)

   On March 12, 1999, the Company issued to InnoCal, Woodside and idealab!
convertible promissory notes totaling $750,000 and bearing an interest rate of
10% per annum. The unpaid principal and accrued interest will convert into
shares of the Company's Series A Preferred Stock at a rate of $0.60 per share.
In connection with the issuance of these convertible notes, 240,000 warrants
for the purchase of common stock at a price of $0.60 per share were issued to
Woodside, InnoCal, and idealab! In addition, the holders of the warrants may
convert the warrants into common stock, without any additional consideration
paid. The number of shares of common stock into which the warrants convert is
dependent upon the fair market value of the Company's common stock at the date
of conversion. These warrants expire in March 2004, to the extent not
previously exercised. At the date of grant, the warrants have been valued at
$8,400 and have been treated as a discount to the convertible notes issued and
as additional Preferred Stock contribution.

   Also on March 12, 1999, $749,012 in outstanding convertible promissory
notes, plus $49,176 in accrued interest, were converted into 1,330,313 shares
of the Company's Series A Preferred Stock.

   On April 5, 1999, the Company issued to Oasis Ventures (Oasis) and other
investors $767,187 in convertible promissory notes, bearing interest at a rate
of 10% per annum. The unpaid principal balance and accrued interest will
convert into shares of the Company's Series B Preferred Stock at a rate of
$0.81 per share. In connection with the issuance of these convertible notes,
265,730 warrants for the purchase of common stock at a price of $0.06 per share
were issued to Oasis and other investors. In addition, the holders of the
warrants may convert the warrants into common stock, without any additional
consideration paid. The number of shares of common stock into which the
warrants convert is dependent upon the fair market value of the Company's
common stock at the date of conversion. These warrants expire in March 2004, to
the extent not previously exercised. At the date of grant, the warrants have
been valued at $152,794 and have been treated as a discount to convertible
notes issued and as additional paid-in capital.

   On July 28, 1999, the Company issued to InnoCal, Woodside and idealab!
$112,500 in convertible promissory notes. The notes are due upon demand and
bear interest at a rate of 8% per annum. The unpaid principal balance and
accrued interest will automatically be converted into shares of the Company's
Series B Preferred Stock at a rate of $0.81 per share.

   In August 1999, the Company issued 5,670,818 shares of Series B Preferred
Stock at a price of $0.81 per share, for $4,593,362. Additionally, $1,693,214
in outstanding convertible promissory notes were converted into 2,090,387
shares of the Company's Series B Preferred Stock.

   The Series A Preferred Stock is convertible into common stock at the
holder's option at any time after issuance. The rate of conversion into common
stock is determined by the product of multiplying the number of Series A
Preferred shares being converted by the Series A Preferred Conversion Rate,
which shall initially be 1:1 but may change pursuant to the terms of the Stock

                                      F-10
<PAGE>

                              TRIVIDA CORPORATION
                         (A Development Stage Company)

                   NOTES TO FINANCIAL STATEMENTS--(Continued)
           (Information at December 31, 1999 and for the nine months
                 ended December 31, 1998 and 1999 is unaudited)

Purchase Agreement. All Series A Preferred Stock will be automatically
converted into common stock upon the affirmative election of the holders of at
least a majority of the outstanding shares of Series A Preferred Stock or upon
the completion of a public offering with proceeds of at least $15 million and a
total Company valuation of at least $75 million. The voting rights of the
Series A Preferred Stock are equal to the number of shares of common stock into
which such shares may be converted on a 1:1 basis. Each share of Series A
Preferred Stock entitles the holder to receive cash dividends at a rate of 8%
per annum of the original issue price of $0.60 per share. The dividends are
payable at the declaration and discretion of the Board of Directors and are
non-cumulative.

   The Series B Preferred Stock is convertible into common stock at the
holder's option at any time after issuance. The rate of conversion into common
stock is determined by the product of the number of Series B Preferred shares
being converted and the Series B Preferred Conversion Rate, which shall
initially be 1:1 but may change pursuant to the terms of the Series B Preferred
Stock Purchase Agreement. All Series B Preferred Stock will automatically be
converted into common stock upon the affirmative election of the holders of at
least a majority of the outstanding shares of Series B Preferred Stock or upon
the completion of a public offering with proceeds of at least $15 million and a
total Company valuation of at least $75 million. The voting rights of the
Series B Preferred Stock are equal to the number of shares into which such
shares may be converted on a 1:1 basis. Each share of Series B Preferred Stock
entitles the holder to receive cash dividends at a rate of 8% per annum of the
original purchase price of $0.81 per share. Dividends are payable at the
declaration and discretion of the Board of Directors and are non-cumulative.

   The Company's Articles of Incorporation have been amended from time to time
to, among other matters, adjust its authorized number of shares of preferred
and common stock. In addition, in June 1998, the Company authorized a stock
split of its Series A Preferred Stock, whereby every three shares of Series A
Preferred Stock became five shares. All information in these financial
statements related to shares of Series A Preferred Stock has been adjusted to
reflect this stock split.

   At March 31, 1999, 12,773,250 shares of common stock were reserved for
future issuance, of which 1,900,000 were reserved for issuance under the
Company's stock option plan, 11,000,000 were reserved for issuance upon the
conversion of Preferred Stock, 1,250,000 were reserved for issuance upon the
conversion of the convertible promissory notes and 365,000 were reserved for
issuance upon the exercise of stock purchase warrants. In July 1999, the
Company amended its Articles of Incorporation to increase the authorized number
of shares of common stock to 30,000,000 shares.

4. Stock Option Plan

   The Company has adopted a Stock Option Plan (the Plan), which provides for
the granting of options for the purchase of up to 1,900,000 (1,000,000 at March
31, 1998) shares of the Company's common stock. Under the Plan, incentive
options to purchase shares may be granted to employees of the Company.
Nonqualified options to purchase shares may be issued to employees, directors,
and

                                      F-11
<PAGE>

                              TRIVIDA CORPORATION
                         (A Development Stage Company)

                   NOTES TO FINANCIAL STATEMENTS--(Continued)
           (Information at December 31, 1999 and for the nine months
                 ended December 31, 1998 and 1999 is unaudited)

consultants of the Company. Under the terms of the Plan, the exercise price of
the incentive and nonqualified options cannot be less than the fair market
value at the date of grant. Options principally vest over a period of four
years from the date of grant and generally expire ten years from such grant.

   The Company has granted 11,800 and 45,000 options to certain consultants for
services rendered as of March 31, 1998 and 1999, respectively. As of March 31,
1999, 11,800 of these options have an exercise price of $1.80 per share, 5,000
have an exercise price of $0.60 per share and 40,000 have an exercise price of
$0.06 per share. The estimated fair value of these options has been recognized
as additional paid-in capital and related expense in the amounts of $21,240 and
$24,200 for the years ended March 31, 1998 and 1999, respectively.

   The Company has granted 70,000 options and 127,084 warrants for the purchase
of the Company's common stock to certain consultants for services rendered
during the nine month period ended December 31, 1999. As of December 31, 1999,
the 70,000 options have an exercise price of $0.20 per share. The estimated
fair market value of these options has been recognized as additional paid-in
capital and related expense in the amount of $37,100 for the nine month period
ended December 31, 1999. At the date of grant, the warrants have been valued at
$107,851 and have been recognized as additional paid-in capital and related
expense.

   A summary of the Company's stock option activity and related information is
as follows:

<TABLE>
<CAPTION>
                                                   Outstanding Stock Options
                                                 ------------------------------
                                                            Weighted
                                                            Average
                                                            Exercise
                                                             Price    Exercise
                                                 Number of    Per    Price Per
                                                  Options    Share     Share
     <S>                                         <C>        <C>      <C>
     Outstanding at March 31, 1997..............       --    $ --    $      --
       Granted..................................   664,800    0.09    0.06-1.80
                                                 ---------   -----   ----------
     Outstanding at March 31, 1998..............   664,800    0.09    0.06-1.80
       Granted.................................. 1,231,000    0.06      0.06
       Exercised................................   (26,750)   0.06      0.06
       Forfeited................................   (79,250)   0.06      0.06
                                                 ---------   -----   ----------
     Outstanding at March 31, 1999.............. 1,789,800   $0.07   $0.06-1.80
       Granted.................................. 2,436,500    0.19    0.06-0.20
       Exercised................................  (858,749)   0.06    0.06-0.20
       Forfeited................................   (30,667)   0.16    0.06-0.20
                                                 ---------   -----   ----------
     Outstanding at December 31, 1999........... 3,336,884    0.16    0.06-1.80
                                                 =========   =====   ==========
     Exercisable at:
       March 31, 1998...........................    14,800   $1.45   $0.06-1.80
       March 31, 1999...........................   334,540   $0.13   $0.06-1.80
       December 31, 1999........................   835,220   $0.10   $0.06-1.80
                                                 =========   =====   ==========
</TABLE>

                                      F-12
<PAGE>

                              TRIVIDA CORPORATION
                         (A Development Stage Company)

                   NOTES TO FINANCIAL STATEMENTS--(Continued)
           (Information at December 31, 1999 and for the nine months
                 ended December 31, 1998 and 1999 is unaudited)


   At March 31, 1998 and 1999, 335,200 and 110,200 shares, respectively, were
available for future grant. The weighted average remaining contractual life for
the outstanding options was 8.46 years at March 31, 1999.

   The excess of the deemed fair value of the Company's common stock over the
exercise price of options granted during the years ended March 31, 1998 and
1999 and the nine months ended December 31, 1999, at the date of grant amounted
to $286,560, $545,280 and $1,228,725, respectively. The deemed fair value of
the common stock was determined by the Company based on the selling prices of
contemporaneous sales of Series A Preferred Stock considering the relative
rights and privileges of each security, the stages of development of the
Company's business, and the inherent risks and perceived future potential of
the Company at the time of grant or issuance. The typical vesting period of the
options is 25% after the first year from grant with the remaining balance
vesting evenly over the following three years. The amortization of deferred
compensation will be charged to operations on a graded methodology basis,
consistent with the method described in Financial Accounting Standards Board
Interpretation No. 28, over the vesting period of the options. During the years
ended March 31, 1998 and 1999 and the nine month period ended December 31,
1999, amortization of deferred compensation of $83,962, $230,378 and $286,135,
respectively, was recorded. Had compensation cost for the Company's stock-based
compensation plan been determined consistent with the fair value approach set
forth in SFAS No. 123, the Company's net losses for the years ended March 31,
1998 and 1999, would have been as follows:

<TABLE>
<CAPTION>
                                                          1998         1999
      <S>                                              <C>          <C>
      Net loss as reported............................ $(2,887,017) $(4,334,153)
      APB No. 25 compensation expense recorded........      83,962      230,378
      Stock-based compensation under SFAS No. 123.....      (5,447)     (45,726)
                                                       -----------  -----------
      Pro forma net loss.............................. $(2,808,502) $(4,149,501)
                                                       ===========  ===========
</TABLE>

   The fair value of options granted during the years ended March 31, 1998 and
1999, are estimated on the date of grant using the minimum value method with
the following weighted-average assumptions: no dividend yield; risk-free
interest rates ranging from 4.5% to 5.5%; and an expected life of four years.
At March 31, 1998 and 1999, deferred compensation of $202,598 and $517,500,
respectively, was reflected as a reduction of stockholders' equity. The
deferred compensation amortization relates only to stock options awarded to
employees; the salaries and related benefits of these employees are included in
the applicable operating expense line item.

5. Line of Credit

   On May 30, 1997, the Company entered into a QuickStart Loan Agreement (Loan
Agreement) with Silicon Valley Bank, which was amended on November 30, 1998.
The Loan Agreement allows for borrowings up to $99,825 and matures on May 30,
1999. Borrowings bear interest at the

                                      F-13
<PAGE>

                              TRIVIDA CORPORATION
                         (A Development Stage Company)

                   NOTES TO FINANCIAL STATEMENTS--(Continued)
           (Information at December 31, 1999 and for the nine months
                 ended December 31, 1998 and 1999 is unaudited)

prevailing prime rate, as defined, plus 2.0% (10.5% at March 31, 1998, and
9.75% at March 31, 1999).

   In connection with the renewal of the Loan Agreement in November 1999, the
Company issued to Silicon Valley Bank 86,420 warrants to purchase the shares of
the Company's Series B Preferred Stock at a price of $0.81 per share. In
addition, the warrants may be converted, on a net basis, into shares of Series
B Preferred Stock without any additional consideration paid. These warrants
expire in November 2009, to the extent not previously exercised. At the date of
grant, the warrants have been valued at $70,000 and have been treated as a
deferred financing cost and as an additional Series B Preferred Stock
contribution.

6. Commitments

   The Company conducts its operations in a leased facility. The lease expires
in December 2004. Rent expense related to this lease amounted to $88,372 and
$184,104 for the years ended March 31, 1998 and 1999, respectively. In
addition, the Company leases certain computer equipment and furniture under
capital leases. The cost and accumulated depreciation related to equipment
under capital leases totaled $328,451 and $664,859, and $71,519 and $588,184,
respectively, at March 31, 1998 and 1999. Future minimum payments under these
leases consisted of the following at March 31, 1999:

<TABLE>
<CAPTION>
                                                           Operating  Capital
                                                             Leases    Leases
      <S>                                                  <C>        <C>
      2000................................................ $  184,104 $301,399
      2001................................................    184,104   44,510
      2002................................................    184,104   19,152
      2003................................................    184,104      --
      2004................................................    184,104      --
      Thereafter..........................................    122,736      --
                                                           ---------- --------
      Total minimum lease payments........................ $1,043,256  365,061
                                                           ----------
      Amounts representing interest.......................             (74,843)
                                                                      --------
      Present value of net minimum lease payments
       (including current portion of $237,743)............            $290,218
                                                                      ========
</TABLE>

7. Income Taxes

   No provision for income taxes, other than the state minimum tax of $800, was
recognized for the years ended March 31, 1998, 1999 and December 31, 1999, as a
result of the net loss incurred during such periods.

                                      F-14
<PAGE>

                              TRIVIDA CORPORATION
                         (A Development Stage Company)

                   NOTES TO FINANCIAL STATEMENTS--(Continued)
           (Information at December 31, 1999 and for the nine months
                 ended December 31, 1998 and 1999 is unaudited)


   The components of the Company's deferred tax assets (and related valuation
reserve) are as follows:

<TABLE>
<CAPTION>
                                                              March 31,
                                                       ------------------------
                                                          1998         1999
      <S>                                              <C>          <C>
      Net operating loss carryforwards................ $ 1,097,508  $ 2,665,106
      Other...........................................      86,390      150,790
                                                       -----------  -----------
      Total deferred tax assets.......................   1,183,898    2,815,896
      Valuation reserve...............................  (1,183,898)  (2,815,896)
                                                       -----------  -----------
      Net deferred tax assets......................... $       --   $       --
                                                       ===========  ===========
</TABLE>

   The Company's income tax expense differs from income tax (benefit) computed
at the U.S. federal statutory rate due to deferred tax assets not benefited.
The Company's net operating loss carryforwards could be limited in
circumstances involving a significant change in equity ownership.

   At March 31, 1999 and December 31, 1999, the Company had net operating loss
carryforwards for both federal and state income tax purposes of approximately
$6,700,000 and $11,400,000, respectively. The net operating loss carryforwards
will expire at various dates beginning in 2005 through 2019, if not utilized.

8. Employee Benefit Plans

   Employees of the Company who are at least 21 years of age and have completed
one month of service, are eligible to participate in a defined contribution
retirement plan, under the provisions of Section 401(k) of the Internal Revenue
Code. Employees may contribute 15% of their eligible compensation, up to a
maximum of $10,000. The plan does provide for matching or discretionary
contributions by the Company; however, no such contributions have been made
through March 31, 1999.

9. Related Party Transactions

   The Company has entered into agreements with two of its executives and
shareholders, whereby a portion of their salaries be loaned to the Company.
These loans will be repaid upon the closing of a Third Party Financing, defined
as an equity financing from institutional investors with proceeds of at least
$5 million. As of March 31, 1999, no such Third Party Financing has occurred.
Amounts accrued under these agreements total $173,333, $333,332 and $40,000 for
the years ended March 31, 1998 and 1999 and the nine month period ended
December 31, 1999, respectively.

                                      F-15
<PAGE>

                              TRIVIDA CORPORATION
                         (A Development Stage Company)

                   NOTES TO FINANCIAL STATEMENTS--(Continued)
           (Information at December 31, 1999 and for the nine months
                 ended December 31, 1998 and 1999 is unaudited)


10. Year 2000 (Unaudited)

   The Company has assessed its Year 2000 business risks and its exposure to
computer systems which are date sensitive. Year 2000 risks results from certain
computer programs that were written using two digits rather than four digits to
define the year (for example "99" for 1999). Computer systems and operating
equipment that utilize two digit date definitions may experience processing
problems or failure when the last two digits of a year become "00," as did
occur on January 1, 2000. Based on its evaluation, the Company determined that
certain of its information systems were not Year 2000 compliant and elected to
upgrade or replace such systems. These systems were replaced during fiscal year
1999 and the Company has determined that it is fully Year 2000 compliant. The
cost of this replacement was not material.

11. Event Subsequent to Date of Report of Independent Auditors (Unaudited)

   On February 15, 2000 the Company signed a definitive agreement with Be Free,
Inc. (Be Free), whereby Be Free would acquire all of the Company's issued and
outstanding shares of capital stock for approximately 2,933,276 shares of Be
Free common stock. In addition, Be Free would assume all outstanding options to
acquire the Company's capital stock, pursuant to which an additional 566,592
shares of Be Free common stock may be issued. The sale was completed on
February 29, 2000.

                                      F-16
<PAGE>

                     UNAUDITED PRO FORMA COMBINED CONDENSED

                             FINANCIAL INFORMATION

   The following unaudited pro forma combined condensed financial information
gives effect to the acquisition by Be Free of TriVida in a transaction which
will be accounted for as a purchase. The unaudited pro forma combined condensed
balance sheet is based on the historical balance sheets of Be Free and TriVida
and has been prepared to reflect the acquisition by Be Free of TriVida as if it
had occurred at December 31, 1999. The unaudited pro forma combined condensed
statement of continuing operations is based on the historical statements of
continuing operations of Be Free and TriVida, and combines the results of
continuing operations of Be Free for the year ended December 31, 1999 and the
twelve months ended December 31, 1999 of TriVida, as if the acquisition
occurred on January 1, 1999. TriVida's fiscal year ends on March 31. The
results of continuing operations for TriVida for the twelve months ended
December 31, 1999 were created using the unaudited results of operations of
TriVida for the nine months ended December 31, 1999 and adding the unaudited
results of operations of TriVida for its three months ended March 31, 1999.

   The pro forma combined condensed financial information is presented for
illustrative purposes only and is not necessarily indicative of the financial
position or operating results that would have been achieved if the acquisition
had been consummated as of the beginning of the period presented, nor are they
necessarily indicative of the future financial position or operating results of
Be Free. The pro forma combined condensed financial information does not give
effect to any cost savings or restructuring and integration costs which may
result from the integration of Be Free and TriVida operations. Such costs
related to restructuring and integration have not yet been determined and Be
Free expects to charge such costs to operations during the quarter incurred.

   The unaudited pro forma combined condensed financial information is based on
continuing operations only and excludes the results of extraordinary items.

   The unaudited pro forma combined condensed financial information should be
read in conjunction with the financial statements and notes thereto of Be Free
and TriVida included elsewhere in this prospectus.

                                      F-17
<PAGE>

                     UNAUDITED PRO FORMA COMBINED CONDENSED
                     BALANCE SHEET AS OF DECEMBER 31, 1999

<TABLE>
<CAPTION>
                                                       Pro Forma        Pro Forma
                            Be Free       TriVida     Adjustments        Combined
<S>                       <C>           <C>           <C>              <C>
         ASSETS
Current assets:
 Cash and cash
  equivalents...........  $ 58,975,906  $  1,308,291  $        --      $ 60,284,197
 Marketable securities..    12,761,659           --            --        12,761,659
 Accounts receivable,
  net...................     1,328,406           --            --         1,328,406
 Prepaid expenses.......     1,012,791           --            --         1,012,791
 Other current assets...       269,526           --            --           269,526
                          ------------  ------------  ------------     ------------
  Total current assets..    74,348,288     1,308,291           --        75,656,579
Marketable securities...     7,954,400           --            --         7,954,400
Property and equipment,
 net....................     7,966,868     2,059,545           --        10,026,413
Intangible assets, net..           --            --    161,641,951 (1)  161,641,951
Other assets............       567,288       185,451           --           752,739
                          ------------  ------------  ------------     ------------
  Total assets..........  $ 90,836,844  $  3,553,287  $161,641,951     $256,032,082
                          ============  ============  ============     ============
    LIABILITIES AND
  STOCKHOLDERS' EQUITY
Current liabilities:
 Accounts payable and
  accrued expenses......  $  3,883,161  $    412,919  $  2,865,000 (2) $  7,161,080
 Deferred revenue.......       942,537           --            --           942,537
 Current portion of
  long-term debt........       942,770       968,936           --         1,911,706
                          ------------  ------------  ------------     ------------
  Total current
   liabilities..........     5,768,468     1,381,855     2,865,000       10,015,323
Long-term debt, net of
 current portion........     2,507,357       807,251           --         3,314,608
                          ------------  ------------  ------------     ------------
  Total liabilities.....     8,275,825     2,189,106     2,865,000       13,329,931
                          ------------  ------------  ------------     ------------
Stockholders' equity:
 Series A and B
  convertible preferred
  stock.................           --     12,818,865   (12,818,865)(3)          --
 Common stock...........       280,882        75,470        14,361 (4)      295,243
                                                           (75,470)(3)
 Additional paid-in
  capital...............   113,413,819     2,403,810   160,126,771 (4)  273,540,590
                                                        (2,403,810)(3)
 Stockholders' notes
  receivable............      (208,072)          --            --          (208,072)
 Unearned compensation..    (6,001,938)   (1,460,150)    1,460,150 (3)   (6,001,938)
 Accumulated other
  comprehensive loss....       (10,818)          --            --           (10,818)
 Accumulated deficit....   (24,876,107)  (12,473,814)   12,473,814 (3)  (24,876,107)
                          ------------  ------------  ------------     ------------
                            82,597,766     1,364,181   158,776,951      242,738,898
 Treasury stock, at
  cost..................       (36,747)          --            --           (36,747)
                          ------------  ------------  ------------     ------------
  Total stockholders'
   equity...............    82,561,019     1,364,181   158,776,951      242,702,151
                          ------------  ------------  ------------     ------------
  Total liabilities and
   stockholders' equity.  $ 90,836,844  $  3,553,287  $161,641,951     $256,032,082
                          ============  ============  ============     ============
</TABLE>

 See accompanying notes to the unaudited pro forma combined condensed financial
                                  information.

                                      F-18
<PAGE>

                UNAUDITED PRO FORMA COMBINED CONDENSED STATEMENT
         OF CONTINUING OPERATIONS FOR THE YEAR ENDED DECEMBER 31, 1999

<TABLE>
<CAPTION>
                                                      Pro Forma       Pro Forma
                            Be Free       TriVida    Adjustments       Combined
<S>                       <C>           <C>          <C>             <C>
Revenue.................  $  5,328,675  $       --   $        --     $  5,328,675
Operating expenses:
  Cost of revenue ......       844,838          --            --          844,838
  Sales and marketing...     9,329,446    1,736,642           --       11,066,088
  Client services ......     3,473,583          --            --        3,473,583
  Development and
   engineering..........     4,767,382    1,328,112           --        6,095,494
  General and
   administrative.......     2,823,412    2,530,149           --        5,353,561
  Equity related
   compensation.........     1,942,147      352,328           --        2,294,475
  Amortization of
   goodwill and
   intangible assets....           --           --     53,897,278(1)   53,897,278
                          ------------  -----------  ------------    ------------
    Total operating
     expenses...........    23,180,808    5,947,231    53,897,278      83,025,317
                          ------------  -----------  ------------    ------------
    Operating loss......   (17,852,133)  (5,947,231)  (53,897,278)    (77,696,642)
Interest income
 (expense), net.........       347,721     (279,585)          --           68,136
Provision for income
 taxes..................           --          (800)          --             (800)
                          ------------  -----------  ------------    ------------
Loss from continuing
 operations.............  $(17,504,412) $(6,227,616) $(53,897,278)   $(77,629,306)
                          ============  ===========  ============    ============
Basic and diluted loss
 from continuing
 operations per common
 share(5)...............  $      (0.92)                              $      (3.55)
Basic and diluted
 weighted average number
 of common shares(5)....    18,951,340                                 21,884,616
</TABLE>



 See accompanying notes to the unaudited pro forma combined condensed financial
                                  information.

                                      F-19
<PAGE>

          NOTES TO PRO FORMA COMBINED CONDENSED FINANCIAL INFORMATION

A. Pro forma Basis of Presentation and Adjustments

   The following unaudited pro forma combined condensed financial information
gives effect to the acquisition by Be Free of TriVida in a transaction which
will be accounted for as a purchase. The unaudited pro forma combined condensed
balance sheet is based on the balance sheets of Be Free and TriVida and has
been prepared to reflect the acquisition by Be Free of TriVida as if it had
occurred at December 31, 1999. The unaudited pro forma combined condensed
statement of continuing operations is based on the individual statements of
continuing operations of Be Free and TriVida, and combines the results of
continuing operations of Be Free for the year ended December 31, 1999 and the
twelve months ended December 31, 1999 of TriVida, as if the acquisition
occurred on January 1, 1999. TriVida's fiscal year ends on March 31. The
results of continuing operations for TriVida for the twelve months ended
December 31, 1999 were created using the unaudited results of operations of
TriVida for the nine months ended December 31, 1999 and adding the unaudited
results of operations of TriVida for its three months ended March 31, 1999.

   On February 29, 2000, Be Free issued 2,933,276 shares of Be Free common
stock in exchange for all outstanding shares of common and preferred stock of
TriVida. Be Free also issued options exercisable for 566,592 shares of common
stock in replacement of outstanding options for common stock of TriVida.

B. Pro Forma Adjustments to Pro Forma Combined Condensed Financial Information

  1. Be Free estimates the purchase price for TriVida to be approximately
     $163.0 million based on the consideration paid to TriVida shareholders
     including common stock and options, plus acquisition related expenses.
     For purposes of measuring the value of the transaction, the value of the
     common stock issued was based on the average closing price of Be Free's
     common stock two days before and after the parties agreed to the terms
     of the acquisition and the terms were announced. The value of options
     issued was estimated using the Black Scholes valuation model. Be Free is
     currently in the process of performing a full assessment of the fair
     value of the net assets acquired. For the purposes of the preparation of
     the pro forma combined condensed financial information, Be Free has
     allocated approximately $1.4 million of the purchase price to tangible
     assets acquired and liabilities assumed based on the book value as of
     December 31, 1999. The remainder has been allocated to intangible assets
     which are expected to include: completed technology, workforce,
     trademarks and goodwill. Based on an estimated useful life of three
     years for such intangible assets, the unaudited pro forma combined
     condensed financial information includes an adjustment of approximately
     $54.0 million for amortization expense. The allocation of the purchase
     price to tangible and intangible assets, as well as the related
     amortization expense, may change materially as a result of the
     completion of Be Free's evaluation of the fair value of the net assets
     acquired.

                                      F-20
<PAGE>


                                  SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date:  March 14, 2000

                              BE FREE, INC.

                              By: /s/ Stephen M. Joseph
                                  -------------------------------------
                                  Stephen M. Joseph
                                  Chief Financial Officer and Treasurer



<PAGE>

                                 EXHIBIT INDEX

     Exhibit 2   Agreement and Plan of Merger, dated February 15, 2000 by and
                 among Be Free, Inc., Cyrano Acquisition Corp. and TriVida
                 Corporation.

     Exhibit 23  Consent of Ernst & Young LLP.

<PAGE>

                                                                       EXHIBIT 2


                          AGREEMENT AND PLAN OF MERGER

                                  BY AND AMONG

                                 BE FREE, INC.,

                            CYRANO ACQUISITION CORP.,

                                       AND

                               TRIVIDA CORPORATION



                                FEBRUARY 15, 2000
<PAGE>

                                TABLE OF CONTENTS

<TABLE>
<CAPTION>
                                                                           Page
                                                                           ----
<S>                                                                        <C>
ARTICLE I.  THE MERGER...................................................     1

 1.1  The Merger.........................................................     1
 1.2  The Closing........................................................     1
 1.3  Actions at the Closing.............................................     1
 1.4  Additional Action..................................................     2
 1.5  Conversion of Shares...............................................     2
 1.6  Dissenting Shares..................................................     3
 1.7  Fractional Shares..................................................     4
 1.8  Options and Warrants...............................................     4
 1.9  Escrow.............................................................     5
 1.10  Articles of Incorporation and By-laws.............................     6
 1.11  No Further Rights.................................................     6
 1.12  Closing of Transfer Books.........................................     6
 1.13  Surrender of Certificates and Exchange of Shares..................     6
 1.14  No Further Ownership Rights in Company Shares.....................     7
 1.15  Lost, Stolen or Destroyed Certificates............................     7
 1.16  Tax Consequences..................................................     7

ARTICLE II.  REPRESENTATIONS AND WARRANTIES OF THE COMPANY...............     8

 2.1  Organization, Qualification and Corporate Power....................     8
 2.2  Capitalization.....................................................     8
 2.3  Authorization of Transaction.......................................     9
 2.4  Noncontravention...................................................     9
 2.5  Subsidiaries.......................................................    10
 2.6  Financial Statements...............................................    10
 2.7  Absence of Certain Changes.........................................    10
 2.8  Undisclosed Liabilities............................................    10
 2.9  Tax Matters........................................................    11
 2.10  Assets............................................................    12
 2.11  Real Property.....................................................    12
 2.12  Real Property Leases..............................................    12
 2.13  Intellectual Property.............................................    13
 2.14  Year 2000 Compliance..............................................    14
 2.15  Contracts.........................................................    15
 2.16  Powers of Attorney................................................    16
 2.17  Insurance.........................................................    16
 2.18  Litigation........................................................    17
 2.19  Warranties........................................................    17
 2.20  Employees.........................................................    17
</TABLE>

                                       -i-
<PAGE>

<TABLE>

<S>                                                                            <C>
 2.21  Employee Benefits......................................................  18
 2.22  Environmental Matters..................................................  19
 2.23  Legal Compliance.......................................................  20
 2.24  Suppliers..............................................................  20
 2.25  Permits................................................................  20
 2.26  Certain Business Relationships With Affiliates.........................  21
 2.27  Brokers' Fees..........................................................  21
 2.28  Books and Records......................................................  21
 2.29  Proxy Statement........................................................  21
 2.30  Disclosure.............................................................  21

ARTICLE III.  REPRESENTATIONS AND WARRANTIES OF THE BUYER AND THE
 TRANSITORY SUBSIDIARY........................................................  22

 3.1  Organization, Qualification and Corporate Power.........................  22
 3.2  Capitalization..........................................................  22
 3.3  Authorization of Transaction............................................  22
 3.4  Noncontravention........................................................  23
 3.5  Reports and Financial Statements........................................  23
 3.6  Interim Operations of the Transitory Subsidiary.........................  24
 3.7  Brokers' Fees...........................................................  24
 3.8  Proxy Statement.........................................................  24
 3.9  Absence of Certain Changes..............................................  24
 3.10  Disclosure.............................................................  24

ARTICLE IV.  COVENANTS........................................................  24

 4.1  Closing Efforts.........................................................  24
 4.2  Governmental and Third-Party Notices and Consents.......................  24
 4.3  Shareholder Approval....................................................  25
 4.4  Operation of Business...................................................  26
 4.5  Access to Information...................................................  27
 4.6  Notice of Breaches......................................................  28
 4.7  Exclusivity.............................................................  28
 4.8  Expenses................................................................  28
 4.9  [Intentionally Omitted].................................................  29
 4.10  Listing of Merger Shares...............................................  29
 4.11  S-8 Registration.......................................................  29
 4.12  Retention Options......................................................  29
 4.13  Employee Benefits......................................................  29
 4.14  Indemnification........................................................  29

ARTICLE V.  CONDITIONS TO CONSUMMATION OF MERGER..............................  30

 5.1  Conditions to Each Party's Obligations..................................  30

</TABLE>
                                      -ii-
<PAGE>

<TABLE>


<S>                                                                                  <C>
 5.2  Conditions to Obligations of the Buyer and the Transitory Subsidiary........    30
 5.3  Conditions to Obligations of the Company....................................    31

ARTICLE VI.  INDEMNIFICATION......................................................    32

 6.1  Indemnification by the Company Shareholders.................................    32
 6.2  Indemnification by the Buyer................................................    33
 6.3  Indemnification Claims......................................................    33
 6.4  Survival of Representations and Warranties..................................    36
 6.5  Limitations.................................................................    37

ARTICLE VII.  TERMINATION.........................................................    37

 7.1  Termination of Agreement....................................................    37
 7.2  Effect of Termination.......................................................    38

ARTICLE VIII.  REGISTRATION RIGHTS................................................    38

 8.1  Certain Definitions.........................................................    38
 8.2  Resale Holder Registration..................................................    39
 8.3  Company Registration........................................................    41
 8.4  Suspension of Prospectus....................................................    42
 8.5  Expenses....................................................................    42
 8.6  Indemnification.............................................................    42
 8.7  Limitation on Assignment of Registration Rights.............................    44

ARTICLE IX.  DEFINITIONS..........................................................    45


ARTICLE X.  MISCELLANEOUS.........................................................    47

 10.1  Press Releases and Announcements...........................................    47
 10.2  No Third Party Beneficiaries...............................................    47
 10.3  Entire Agreement...........................................................    47
 10.4  Succession and Assignment..................................................    47
 10.5  Counterparts; Facsimile Signature..........................................    48
 10.6  Headings...................................................................    48
 10.7  Notices....................................................................    48
 10.8  Governing Law..............................................................    49
 10.9  Amendments and Waivers.....................................................    49
 10.10  Severability..............................................................    49
 10.11  Construction..............................................................    49

</TABLE>

                                      -iii-
<PAGE>

Exhibit A -  Escrow Agreement

Exhibit B -  Voting Agreement and Irrevocable Proxy

Exhibit C -  Employment Agreement

Exhibit D -  Opinion of Counsel to the Company

Exhibit E -  Opinion of Counsel to the Buyer and the Transitory Subsidiary



                                       -i-
<PAGE>

                          AGREEMENT AND PLAN OF MERGER

     Agreement entered into as of February 15, 2000 by and among Be Free, Inc.,
a Delaware corporation (the "Buyer"), Cyrano Acquisition Corp., a Delaware
corporation and a wholly-owned subsidiary of the Buyer (the "Transitory
Subsidiary"), and TriVida Corporation, a California corporation (the "Company").
The Buyer, the Transitory Subsidiary and the Company are referred to
collectively herein as the "Parties."

     This Agreement contemplates a merger of the Transitory Subsidiary into the
Company. In such merger, the shareholders of the Company will receive common
stock of the Buyer in exchange for their capital stock of the Company.

     Now, therefore, in consideration of the representations, warranties and
covenants herein contained, the Parties agree as follows.

                                   ARTICLE I.
                                   THE MERGER

     1.1 The Merger. Upon and subject to the terms and conditions of this
Agreement, the Transitory Subsidiary shall merge with and into the Company (with
such merger referred to herein as the "Merger") at the Effective Time (as
defined below). From and after the Effective Time, the separate corporate
existence of the Transitory Subsidiary shall cease and the Company shall
continue as the surviving corporation in the Merger (the "Surviving
Corporation"). The "Effective Time" shall be the time at which the Surviving
Corporation files the agreement of merger or other appropriate documents
prepared and executed in accordance with Section 1103 of the California General
Corporation Law and Section 252 of the Delaware General Corporation Law (the
"Certificate of Merger") with the Secretaries of State of the States of
California and Delaware. The Merger shall have the effects set forth in Section
1107 of the California General Corporation Law and Section 259 of the Delaware
General Corporation Law.

     1.2 The Closing. The closing of the transactions contemplated by this
Agreement (the "Closing") shall take place at the offices of Hale and Dorr LLP
in Boston, Massachusetts, commencing at 9:00 a.m. local time on February 29,
2000, or, if all of the conditions to the obligations of the Parties to
consummate the transactions contemplated hereby have not been satisfied or
waived by such date, on such mutually agreeable later date as soon as
practicable (and in any event not later than three business days) after the
satisfaction or waiver of all conditions (excluding the delivery of any
documents to be delivered at the Closing by any of the Parties) set forth in
Article V hereof (the "Closing Date").

     1.3 Actions at the Closing. At the Closing:

         (a) the Company shall deliver to the Buyer and the Transitory
Subsidiary the various certificates, instruments and documents referred to in
Section 5.2;

         (b) the Buyer and the Transitory Subsidiary shall deliver to the
Company the various certificates, instruments and documents referred to in
Section 5.3;
<PAGE>

         (c)the Surviving Corporation shall file with the Secretaries of State
of the States of California and Delaware the Certificate of Merger;

         (d) the Buyer, James Houlihan, Alex Jacobson and Peter Price (the
"Indemnification Representatives") and a financial institution selected by the
Buyer prior to the Effective Time and reasonably acceptable to the
Indemnification Representatives (the "Escrow Agent") shall execute and deliver
the Escrow Agreement attached hereto as Exhibit A (the "Escrow Agreement") and
the Buyer shall deliver to the Escrow Agent a certificate for the Escrow Shares
(as defined below) being placed in escrow on the Closing Date pursuant to
Section 1.9.

     1.4 Additional Action. The Surviving Corporation may, at any time after the
Effective Time, take any action, including executing and delivering any
document, in the name and on behalf of either the Company or the Transitory
Subsidiary, in order to consummate the transactions contemplated by this
Agreement.

     1.5 Conversion of Shares. At the Effective Time, by virtue of the Merger
and without any action on the part of any Party or the holder of any of the
following securities:

         (a) Each share of (i) common stock, without par value, of the Company
("Common Shares"), (ii) Series A Preferred Stock, without par value, of the
Company ("Series A Shares"), and (iii) Series B Preferred Stock without par
value, of the Company ("Series B Shares" and collectively with the Series A
Shares, the "Preferred Shares") issued and outstanding immediately prior to the
Effective Time (other than Common Shares or Preferred Shares owned beneficially
by the Buyer or the Transitory Subsidiary, Dissenting Shares (as defined below)
and Common Shares or Preferred Shares held in the Company's treasury) shall be
converted into and represent the right to receive (subject to the provisions of
Section 1.10) that number of shares of common stock, $.01 par value per share,
of the Buyer ("Buyer Common Stock") as is set forth in Section 1.5(c) below,
which number shall be based upon the Conversion Ratio (as defined below). The
Preferred Shares and the Common Shares are collectively referred to herein as
"Company Shares."

         (b) The "Conversion Ratio" shall be the result obtained by dividing (i)
1,634,504 by (ii) the sum of (A) the number of outstanding Company Shares
immediately prior to the Effective Time and (B) the number of Company Shares
issuable upon exercise of all Options and Warrants outstanding immediately prior
to the Effective Time. The Conversion Ratio shall be subject to equitable
adjustment in the event of any stock split, stock dividend, reverse stock split,
recapitalization or similar event affecting the Buyer Common Stock between the
date hereof and the Effective Time(including without limitation the 2-for-1
stock split to be effected in the form of a 100% stock dividend announced by the
Buyer on the date hereof (the "Buyer Stock Split") if the Effective Time is
after the record date for such Stock Split and shall be subject to equitable
adjustment in the event of any increase or decrease in the number of Preferred
Shares from the amounts set forth in Section 2.2 hereof. The shareholders of
record of the Company immediately prior to the Effective Time (the "Company
Shareholders") shall be entitled to receive immediately 90% of the shares of
Buyer Common Stock into which their Company Shares were converted pursuant to
this Section 1.5 (the "Initial Shares"); the

                                      -2-
<PAGE>

remaining 10% of the shares of Buyer Common Stock into which their Company
Shares were converted pursuant to this Section 1.5, rounded to the nearest whole
number (the "Escrow Shares"), shall be deposited in escrow pursuant to Section
1.9 and shall be held and disposed of in accordance with the terms of the Escrow
Agreement. The Initial Shares and the Escrow Shares shall together be referred
to herein as the "Merger Shares."

         (c) The number of shares of Buyer Common Stock into which each Company
Share shall be converted is as follows:

                                  Fraction of a Share of Buyer
                                   Common Stock into Which
     Type of Company Share        Company Share is Converted
     ---------------------        --------------------------

     Common Share...............  Conversion Ratio

     Series A Share.............  Conversion Ratio + 0.005381

     Series B Share.............  Conversion Ratio + 0.007265


         (d) Each Company Share held in the Company's treasury immediately prior
to the Effective Time and each Company Share owned beneficially by the Buyer or
the Transitory Subsidiary shall be cancelled and retired without payment of any
consideration therefor.

         (e) Each share of common stock, $.01 par value per share, of the
Transitory Subsidiary issued and outstanding immediately prior to the Effective
Time shall be converted into and thereafter evidence one share of common stock,
$.01 par value per share, of the Surviving Corporation.

     1.6 Dissenting Shares.

         (a) For purposes of this Agreement, "Dissenting Shares" means Company
Shares held as of the Effective Time by a Company Shareholder who has not voted
such Company Shares in favor of the adoption of this Agreement and the Merger
and with respect to which appraisal shall have been duly demanded and perfected
in accordance with Chapter 13 of the California General Corporation Law and not
effectively withdrawn or forfeited prior to the Effective Time. Dissenting
Shares shall not be converted into or represent the right to receive Merger
Shares, unless such Company Shareholder shall have forfeited his, her or its
right to appraisal under the California General Corporation Law or properly
withdrawn, his, her or its demand for appraisal. If such Company Shareholder has
so forfeited or withdrawn his, her or its right to appraisal of Dissenting
Shares, then (i) as of the occurrence of such event, such holder's Dissenting
Shares shall cease to be Dissenting Shares and shall be converted into and
represent the right to receive the Merger Shares issuable in respect of such
Company Shares pursuant to Section 1.5, and (ii) promptly following the
occurrence of such event, the Buyer shall deliver to such Company Shareholder a
certificate representing 90% of the Merger Shares to which such holder is
entitled pursuant to Section 1.5 (which shares shall be considered Initial
Shares for all purposes of this Agreement) and shall deliver to the Escrow Agent
a certificate representing the

                                      -3-
<PAGE>

remaining 10% of the Merger Shares to which such holder is entitled pursuant to
Section 1.5 (which shares shall be considered Escrow Shares for all purposes of
this Agreement).

         (b) The Company shall give the Buyer (i) prompt notice of any written
demands for appraisal of any Company Shares, withdrawals of such demands, and
any other instruments that relate to such demands received by the Company and
(ii) the opportunity to direct all negotiations and proceedings with respect to
demands for appraisal under the California General Corporation Law. The Company
shall not, except with the prior written consent of the Buyer, make any payment
with respect to any demands for appraisal of Company Shares or offer to settle
or settle any such demands.

     1.7 Fractional Shares. No certificates or scrip representing fractional
Initial Shares shall be issued to former Company Shareholders upon the surrender
for exchange of certificates that, immediately prior to the Effective Time,
represented Company Shares converted into Merger Shares pursuant to Section 1.5
(including any Company Shares referred to in the last sentence of Section
1.6(a)) ("Certificates"), and such former Company Shareholders shall not be
entitled to any voting rights, rights to receive any dividends or distributions
or other rights as a stockholder of the Buyer with respect to any fractional
Initial Shares that would have otherwise been issued to such former Company
Shareholders. In lieu of any fractional Initial Shares that would have otherwise
been issued, each former Company Shareholder that would have been entitled to
receive a fractional Initial Share shall, upon proper surrender of such person's
Certificates, receive such whole number of Initial Shares as is equal to the
precise number of Initial Shares to which such person would be entitled, rounded
up or down to the nearest whole number (with a fractional interest equal to .5
rounded to the nearest odd number); provided that each such holder shall receive
at least one Initial Share.

     1.8 Options and Warrants.

         (a) As of the Effective Time, the Company's 1998 Equity Incentive Plan,
as adopted July 24, 1998 and amended October 15, 1998 and October 7, 1999
("Option Plan") and all options to purchase Company Shares issued by the Company
pursuant to Option Plan or otherwise ("Options"), whether vested or unvested,
shall be assumed by the Buyer. Immediately after the Effective Time, each Option
outstanding immediately prior to the Effective Time shall be deemed to
constitute an option to acquire, on the same terms and conditions as were
applicable under such Option at the Effective Time, such number of shares of
Buyer Common Stock as is equal to the number of Company Shares subject to the
unexercised portion of such Option multiplied by the Conversion Ratio (with any
fraction resulting from such multiplication to be rounded down to the nearest
whole number). The exercise price per share of each such assumed Option shall be
equal to the exercise price of such Option immediately prior to the Effective
Time, divided by the Conversion Ratio (rounded up to the nearest whole cent).
The term, exercisability, vesting schedule, status as an "incentive stock
option" under Section 422 of the Internal Revenue Code of 1986 (as amended, the
"Code"), if applicable, and all of the other terms of the Options shall
otherwise remain unchanged.

         (b) As soon as practicable after the Effective Time, the Buyer or the
Surviving Corporation shall deliver to the holders of Options appropriate
notices setting forth

                                      -4-
<PAGE>

such holders' rights pursuant to such Options, as amended by this Section 1.8,
and the agreements evidencing such Options shall continue in effect on the same
terms and conditions (subject to the amendments provided for in this Section 1.8
and such notice).

         (c) The Buyer shall take all corporate action necessary to reserve for
issuance a sufficient number of shares of Buyer Common Stock for delivery upon
exercise of the Options assumed in accordance with this Section 1.8.

         (d) The Company shall cause the termination, as of the Effective Time,
of all warrants to acquire any capital stock of the Company (the "Warrants")
which remain unexercised; except that the Warrants to acquire 86,240 Series B
Shares dated November 16, 1999 held by Silicon Valley Bank (the "SVB Warrant")
may not be terminated and in accordance with the terms thereof shall be
exercisable for shares of Buyer Common Stock. The number of shares of Buyer
Common Stock that may be purchased under this SVB Warrant shall equal the number
of Series B Shares issuable thereunder multiplied by the fraction of a share of
Buyer Common Stock per Series B Share set forth in Section 1.5(c) (with any
fraction resulting from such multiplication to be rounded down to the nearest
whole number) and the exercise per share of Buyer Common Stock that may be
purchased under the SVB Warrant shall equal the exercise price immediately prior
to the Effective Time, divided by the fraction of a share of Buyer Common Stock
per Series B Share set forth in Section 1.5(c) (rounded up to the nearest whole
cent).

         (e) The Company shall obtain, prior to the Closing, the consent from
each holder of an Option or a Warrant to the amendment (in the case of Options
or the SVB Warrant) or termination (in the case of Warrants other than the SVB
Warrant) of such Option or Warrant pursuant to this Section 1.8 (unless such
consent is not required under the terms of the applicable agreement, instrument
or plan).

         (f) Shareholder Loans. In the event that any Company Shareholder owes
monies to the Company under outstanding loans from the Company as of the
Effective Time (except for expense advances), the consideration payable to such
Company Shareholder pursuant to Section 1.5 shall be reduced by an amount equal
to the outstanding principal plus accrued interest of such shareholder's loans
as of the Effective Time.

     1.9 Escrow.

         (a) On the Closing Date, the Buyer shall deliver to the Escrow Agent a
certificate (issued in the name of the Escrow Agent or its nominee) representing
the Escrow Shares, as described in Section 1.5, for the purpose of securing the
indemnification obligations of the Indemnifying Shareholders (as defined in
Section 6.1) set forth in this Agreement. The Escrow Shares shall be held by the
Escrow Agent under the Escrow Agreement pursuant to the terms thereof. The
Escrow Shares shall be held as a trust fund and shall not be subject to any
lien, attachment, trustee process or any other judicial process of any creditor
of any party, and shall be held and disbursed solely for the purposes and in
accordance with the terms of the Escrow Agreement.

                                      -5-
<PAGE>

         (b) The adoption of this Agreement and the approval of the Merger by
the Company Shareholders shall constitute approval of the Escrow Agreement and
of all of the arrangements relating thereto, including without limitation the
placement of the Escrow Shares in escrow and the appointment of the
Indemnification Representatives.

     1.10 Articles of Incorporation and By-laws.

         (a) The Articles of Incorporation of the Surviving Corporation
immediately following the Effective Time shall be the same as the Articles of
Incorporation of the Company immediately prior to the Effective Time, except
that the authorized capitalization shall be reduced to 100,000 Company Common
Shares.

         (b) The By-laws of the Surviving Corporation immediately following the
Effective Time shall be the same as the By-laws of the Company immediately prior
to the Effective Time.

     1.11 No Further Rights. From and after the Effective Time, no Company
Shares shall be deemed to be outstanding, and holders of Certificates shall
cease to have any rights with respect thereto, except as provided herein or by
law.

     1.12 Closing of Transfer Books. At the Effective Time, the stock transfer
books of the Company shall be closed and no transfer of Company Shares shall
thereafter be made. If, after the Effective Time, Certificates are presented to
the Buyer or the Surviving Corporation, they shall be cancelled and exchanged
for Initial Shares in accordance with Section 1.5, subject to Section 1.9 and to
applicable law in the case of Dissenting Shares.

     1.13 Surrender of Certificates and Exchange of Shares.

         (a) The Corporate Secretary of the Buyer or the Buyer's transfer agent
shall serve as the exchange agent (the "Exchange Agent") for the Merger.
Promptly after the Effective Time, the Buyer shall make available to the
Exchange Agent for exchange in accordance with this Article I the shares of
Buyer Common Stock issuable in exchange for outstanding Company Shares; provided
that, on behalf of the Company Shareholders, the Buyer shall issue to the Escrow
Agent a certificate for the Escrow Shares pursuant to Section 1.9. On or
promptly after the Effective Time, the Company Shareholders will surrender the
Certificates to the Exchange Agent for cancellation together with a letter of
transmittal in such customary form and having such customary provisions that the
Buyer may reasonably request. Upon such surrender of a Certificate for
cancellation to the Exchange Agent together with such letter of transmittal,
subject to the terms of Section 1.13(c) hereof, the holder of such Certificate
shall be entitled to receive from the Exchange Agent in exchange therefor a
certificate representing the number of Initial Shares of Buyer Common Stock, and
the Certificate so surrendered shall be canceled. Until so surrendered, each
outstanding Certificate will be deemed from and after the Effective Time and for
all corporate purposes, to evidence only the ownership of the number of full
shares of Buyer Common Stock into which such Company Shares shall have been so
converted.

                                      -6-
<PAGE>

         (b) No dividends or other distributions declared or made after the
Effective Time with respect to Buyer Common Stock with a record date after the
Effective Time will be paid to the holder of any unsurrendered Certificate with
respect to the shares of Buyer Common Stock represented thereby until the holder
of record of such Certificate shall surrender such Certificate. Subject to
applicable law, following surrender of any such Certificate, there shall be paid
to the record holder of the certificates representing whole shares of Buyer
Common Stock issued in exchange therefor, without interest, at the time of such
surrender, the amount of dividends or other distributions with a record date
after the Effective Time theretofore paid with respect to such whole shares of
Buyer Common Stock.

         (c) If any certificate for shares of Buyer Common Stock is to be issued
in a name other than that in which the certificate surrendered in exchange
therefor is registered, it will be a condition of the issuance and/or delivery
thereof that the certificate so surrendered will be properly endorsed and
otherwise in proper form for transfer and that the person requesting such
exchange will have paid to the Buyer or any agent designated by it any transfer
or other taxes required by reason of the issuance of a certificate for shares of
Buyer Common Stock in any name other than that of the registered holder of the
certificate surrendered, or established to the satisfaction of the Buyer or any
agent designated by it that such tax has been paid or is not payable.

         (d) Notwithstanding anything to the contrary in this Section 1.13,
neither the Buyer, the Surviving Corporation nor any party hereto shall be
liable to a holder of Company Shares for any amount properly paid to a public
official pursuant to any applicable abandoned property, escheat or similar law.

     1.14 No Further Ownership Rights in Company Shares. The shares of Buyer
Common Stock paid in respect of the surrender for exchange of Company Shares in
accordance with the terms hereof, shall be deemed to be full satisfaction of all
rights pertaining to such Company Shares, and there shall be no further
registration of transfers on the records of the Surviving Corporation of Company
Shares which were outstanding immediately prior to the Effective Time. If, after
the Effective Time, Certificates are presented to the Surviving Corporation for
any reason, they shall be canceled and exchanged as provided in this Article I.

     1.15 Lost, Stolen or Destroyed Certificates. In the event any Certificates
shall have been lost, stolen or destroyed, the Buyer shall issue in exchange for
such lost, stolen or destroyed Certificates, upon the making of an affidavit of
that fact by the holder thereof, such number of Initial Shares and Escrow Shares
as provided in Section 1.5; provided, however, that the Buyer may, in its
discretion and as a condition precedent to the issuance thereof, require the
stockholder who is the owner of such lost, stolen or destroyed certificates to
deliver a bond in such amount as it may reasonably direct against any claim that
may be made against the Buyer with respect to the certificates alleged to have
been lost, stolen or destroyed.

     1.16 Tax Consequences. It is intended by the parties hereto that the Merger
shall constitute a reorganization within the meaning of Section 368(a) of the
Code. The Buyer and the Company will report the Merger as a reorganization
described in Section 368(a) of the Code, and comply with the provisions of
Treasury Regulation Section 1.368-3.

                                      -7-
<PAGE>

                                  ARTICLE II.
                  REPRESENTATIONS AND WARRANTIES OF THE COMPANY

     The Company represents and warrants to the Buyer that the statements
contained in this Article II are true and correct, except as set forth in the
disclosure schedule provided by the Company to the Buyer on the date hereof and
accepted in writing by the Buyer (the "Disclosure Schedule"). The Disclosure
Schedule shall be arranged in paragraphs corresponding to the numbered and
lettered paragraphs contained in this Article II, and the disclosures in any
paragraph of the Disclosure Schedule shall qualify other paragraphs in this
Article II only to the extent it is reasonably clear from a reading of the
disclosure that such disclosure is applicable to such other paragraphs. For
purposes of this Article II, the phrase "to the knowledge of the Company" or any
phrase of similar import shall be deemed to refer to the actual knowledge of the
officers of the Company (other than the Secretary) and Mr. Ivan Ivankovich after
making reasonable inquiry.

     2.1 Organization, Qualification and Corporate Power. The Company is a
corporation duly organized, validly existing and in corporate and tax good
standing under the laws of the State of California. The Company is duly
qualified to conduct business and is in corporate and tax good standing under
the laws of each jurisdiction in which the nature of its businesses or the
ownership or leasing of its properties requires such qualification, except where
the failure to be so qualified or in good standing, individually or in the
aggregate, has not had and could not reasonably be expected in the future to
have a Company Material Adverse Effect (as defined below). The Company has all
requisite corporate power and authority to carry on the businesses in which it
is engaged and to own and use the properties owned and used by it. The Company
has furnished to the Buyer complete and accurate copies of its Articles of
Incorporation and By-laws. The Company is not in default under or in violation
of any provision of its Articles of Incorporation or By-laws. For purposes of
this Agreement, "Company Material Adverse Effect" means a material adverse
effect on the assets, business, condition (financial or otherwise), or results
of operations of the Company other than any effect primarily and directly
resulting from (a) the execution of this Agreement or the announcement or
pendency of the transactions contemplated hereby, (b) conditions generally
affecting the Company's industry as a whole or (c) the failure to obtain any
additional funding that may be required.

     2.2 Capitalization. The authorized capital stock of the Company consists of
30,000,000 Common Shares and 19,223,694 Preferred Shares, of which, as of the
date of this Agreement, (a) 4,469,499 Common Shares were issued and outstanding,
of which 831,325 shares are subject to a repurchase right in favor of the
Company, (b) 10,723,694 Series A Shares were issued and outstanding, (c)
7,761,205 Series B Shares were issued and outstanding, (d) 18,484,899 Common
Shares were reserved for issuance upon conversion of the Preferred Shares,
3,052,884 Common Shares were reserved for issuance upon exercise of Options and
193,893 shares of Series B Preferred Stock and 632,814 Common Shares were
reserved for issuance upon exercise of Warrants, and (e) no shares were held in
the treasury of the Company. Section 2.2 of the Disclosure Schedule sets forth a
complete and accurate list as of the date of this Agreement of (i) all
shareholders of the Company, indicating the number of Company Shares held by
each shareholder, (ii) all outstanding Options and Warrants, indicating (A) the
holder thereof, (B) the number of Company Shares subject to each Option and
Warrant, (C) the exercise

                                      -8-
<PAGE>

price, date of grant, vesting schedule and expiration date for each Option or
Warrant, and (D) any terms regarding the acceleration of vesting, and (iii) all
stock option plans and other stock or equity-related plans of the Company. All
of the issued and outstanding Company Shares are, and all Company Shares that
may be issued upon exercise of Options or Warrants will be (upon issuance in
accordance with their terms), duly authorized, validly issued, fully paid,
nonassessable and free of all preemptive rights. Other than the Options and
Warrants listed in Section 2.2 of the Disclosure Schedule, as of the date of
this Agreement there are no outstanding or authorized options, warrants, rights,
agreements or commitments to which the Company is a party or which are binding
upon the Company providing for the issuance or redemption of any of its capital
stock. There are no outstanding or authorized stock appreciation, phantom stock
or similar rights with respect to the Company. There are no agreements to which
the Company is a party or by which it is bound with respect to the voting
(including without limitation voting trusts or proxies), registration under the
Securities Act of 1933, as amended (the "Securities Act"), or sale or transfer
(including without limitation agreements relating to pre-emptive rights, rights
of first refusal, co-sale rights or "drag-along" rights) of any securities of
the Company. To the knowledge of the Company, there are no agreements among
other parties, to which the Company is not a party and by which it is not bound,
with respect to the voting (including without limitation voting trusts or
proxies) or sale or transfer (including without limitation agreements relating
to rights of first refusal, co-sale rights or "drag-along" rights) of any
securities of the Company. All of the issued and outstanding Company Shares were
issued in compliance with applicable federal and state securities laws.

     2.3 Authorization of Transaction. The Company has all requisite power and
authority to execute and deliver this Agreement and to perform its obligations
hereunder. The execution and delivery by the Company of this Agreement and,
subject to the adoption of this Agreement and the approval of the Merger by
holders of (a) a majority of the Common Shares, (b) a majority of the Series A
Shares, and (c) a majority of the Series B Shares entitled to vote on this
Agreement and the Merger (the "Requisite Shareholder Approval"), the
consummation by the Company of the transactions contemplated hereby have been
duly and validly authorized by all necessary corporate action on the part of the
Company. Without limiting the generality of the foregoing, the Board of
Directors of the Company, at a meeting duly called and held, by the unanimous
vote of all directors (i) determined that the Merger is fair and in the best
interests of the Company and its shareholders, (ii) adopted this Agreement in
accordance with the provisions of the California General Corporation Law, and
(iii) directed that this Agreement and the Merger be submitted to the
shareholders of the Company for their adoption and approval and resolved to
recommend that the shareholders of Company vote in favor of the adoption of this
Agreement and the approval of the Merger. This Agreement has been duly and
validly executed and delivered by the Company and constitutes a valid and
binding obligation of the Company, enforceable against the Company in accordance
with its terms.

     2.4 Noncontravention. Neither the execution and delivery by the Company of
this Agreement, nor the consummation by the Company of the transactions
contemplated hereby, will (a) conflict with or violate any provision of the
Articles of Incorporation or By-laws of the Company, (b) require on the part of
the Company any filing with, or any permit, authorization, consent or approval
of, any court, arbitrational tribunal, administrative agency or commission or
other governmental or regulatory authority or agency (a "Governmental Entity"),
except for the

                                      -9-
<PAGE>

filing of the Certificate of Merger as required by the California General
Corporation Law, (c) conflict with, result in a breach of, constitute (with or
without due notice or lapse of time or both) a default under, result in the
acceleration of obligations under, create in any party the right to terminate,
modify or cancel, or require any notice, consent or waiver under, any contract
or instrument to which the Company is a party or by which the Company is bound
or to which any of its assets is subject, (d) result in the imposition of any
Security Interest (as defined below) upon any assets of the Company or (e)
violate any order, writ, injunction, decree, statute, rule or regulation
applicable to the Company or any of its properties or assets, subject to the
filing of the Certificate of Merger as required by the California General
Corporation Law. For purposes of this Agreement: "Security Interest" means any
mortgage, pledge, security interest, encumbrance, charge or other lien (whether
arising by contract or by operation of law), other than (i) mechanic's,
materialmen's, and similar liens, (ii) liens arising under worker's
compensation, unemployment insurance, social security, retirement, and similar
legislation, and (iii) liens on goods in transit incurred pursuant to
documentary letters of credit, in each case arising in the Ordinary Course of
Business (as defined below) of the Company and not material to the Company; and
"Ordinary Course of Business" means the ordinary course of the Company's
business, consistent with past custom and practice.

     2.5 Subsidiaries. The Company does not control directly or indirectly or
have any direct or indirect equity participation or similar interest in any
corporation, partnership, limited liability company, joint venture, trust or
other business association.

     2.6 Financial Statements. The Company has provided to the Buyer (a) the
audited consolidated balance sheets and statements of income, changes in
shareholders' equity and cash flows of the Company as of and for the fiscal
years ended March 31, 1998 and March 31, 1999; and (b) the unaudited
consolidated balance sheet and statements of income, changes in shareholders'
equity and cash flows as of and for the month ended as of January 31, 2000 (the
"Most Recent Balance Sheet Date"). Such financial statements (collectively, the
"Financial Statements") have been prepared in accordance with United States
generally accepted accounting principles ("GAAP") applied on a consistent basis
throughout the periods covered thereby (except as may be indicated therein or in
the notes thereto), fairly present the financial condition, results of
operations and cash flows of the Company as of the respective dates thereof and
for the periods referred to therein and are consistent with the books and
records of the Company; provided, however, that the Financial Statements
referred to in clause (b) above are subject to normal recurring year-end
adjustments (which will not in the aggregate be material) and do not include
footnotes.

     2.7 Absence of Certain Changes. Since the Most Recent Balance Sheet Date,
(a) there has occurred no event or development which has had, or could
reasonably be expected to have in the future, a Company Material Adverse Effect,
and (b) the Company has not taken any of the actions set forth in paragraphs (a)
through (n) of Section 4.4 (except that the dollar amounts in Section 4.4(k)
shall be deemed to be $5,000 and $25,000 rather than $2,000 and $10,000,
respectively).

     2.8 Undisclosed Liabilities. The Company does not have any liability
(whether known or unknown, whether absolute or contingent, whether liquidated or
unliquidated and

                                      -10-
<PAGE>

whether due or to become due), except for (a) liabilities shown on the balance
sheet referred to in clause (b) of Section 2.6 (the "Most Recent Balance
Sheet"), (b) liabilities (other than claims for breach of contracts or tort)
which have arisen since the Most Recent Balance Sheet Date in the Ordinary
Course of Business and which are similar in nature and amount to the liabilities
which arose during the comparable period of time in the immediately preceding
fiscal period and (c) liabilities (other than claims for breach of contracts or
tort) incurred in the Ordinary Course of Business which are not required by GAAP
to be reflected on a balance sheet.

     2.9 Tax Matters.

         (a) For purposes of this Agreement, the following terms shall have the
following meanings:

         (i) "Taxes" means all taxes, charges, fees, levies or other similar
assessments or liabilities, including without limitation income, gross receipts,
ad valorem, premium, value-added, excise, real property, personal property,
sales, use, transfer, withholding, employment, unemployment insurance, social
security, business license, business organization, environmental, workers
compensation, payroll, profits, license, lease, service, service use, severance,
stamp, occupation, windfall profits, customs, duties, franchise and other taxes
imposed by the United States of America or any state, local or foreign
government, or any agency thereof, or other political subdivision of the United
States or any such government, and any interest, fines, penalties, assessments
or additions to tax resulting from, attributable to or incurred in connection
with any tax or any contest or dispute thereof.

         (ii) "Tax Returns" means all reports, returns, declarations, statements
or other information required to be supplied to a taxing authority in connection
with Taxes.

         (b) The Company has filed on a timely basis all Tax Returns that it was
required to file, and all such Tax Returns were complete and accurate in all
material respects. The Company is not nor has ever been a member of a group of
corporations with which it has filed (or been required to file) consolidated,
combined or unitary Tax Returns, other than a group of which only the Company is
or was a member. The Company has paid on a timely basis all Taxes that were due
and payable. The unpaid Taxes of the Company for tax periods through the Most
Recent Balance Sheet Date do not exceed the accruals and reserves for Taxes
(excluding accruals and reserves for deferred Taxes established to reflect
timing differences between book and Tax income) set forth on the Most Recent
Balance Sheet. The Company does not have any actual or potential liability for
any Tax obligation of any taxpayer (including without limitation any affiliated
group of corporations or other entities that included the Company during a prior
period) other than the Company. All Taxes that the Company is or was required by
law to withhold or collect have been duly withheld or collected and, to the
extent required, have been paid to the proper Governmental Entity.

         (c) The Company has delivered to the Buyer complete and accurate copies
of all federal income Tax Returns, examination reports and statements of
deficiencies assessed against or agreed to by the Company since its inception.
The Company has delivered or made available to the Buyer complete and accurate
copies of all other Tax Returns of the Company

                                      -11-
<PAGE>

together with all related examination reports and statements of deficiency for
all periods since the Company's inception. No examination or audit of any Tax
Return of the Company by any Governmental Entity is currently in progress or, to
the knowledge of the Company, threatened or contemplated. The Company has not
been informed by any jurisdiction that the jurisdiction believes that the
Company was required to file any Tax Return that was not filed. The Company has
not waived any statute of limitations with respect to Taxes or agreed to an
extension of time with respect to a Tax assessment or deficiency.

         (d) The Company: (i) is not a "consenting corporation" within the
meaning of Section 341(f) of the Code, and none of the assets of the Company are
subject to an election under Section 341(f) of the Code; (ii) has not been a
United States real property holding corporation within the meaning of Section
897(c)(2) of the Code during the applicable period specified in Section
897(c)(l)(A)(ii) of the Code; (iii) has not made any payments, is not obligated
to make any payments, and is not a party to any agreement that could obligate it
to make any payments that may be treated as an "excess parachute payment" under
Section 280G of the Code; (iv) does not have any actual or potential liability
for any Taxes of any person (other than the Company) under Treasury Regulation
Section 1.1502-6 (or any similar provision of federal, state, local, or foreign
law), or as a transferee or successor, by contract, or otherwise; or (v) is not
nor has been required to make a basis reduction pursuant to Treasury Regulation
Section 1.1502-20(b) or Treasury Regulation Section 1.337(d)-2(b).

         (e) None of the assets of the Company: (i) is property that is required
to be treated as being owned by any other person pursuant to the provisions of
former Section 168(f)(8) of the Code; (ii) is "tax-exempt use property" within
the meaning of Section 168(h) of the Code; or (iii) directly or indirectly
secures any debt the interest on which is tax exempt under Section 103(a) of the
Code.

         (f) The Company has not undergone a change in its method of accounting
resulting in an adjustment to its taxable income pursuant to Section 481 of the
Code.

     2.10 Assets. The Company owns or leases all tangible assets necessary for
the conduct of its business as presently conducted. No asset of the Company
(tangible or intangible) is subject to any Security Interest. All of the
tangible assets of the Company are located at the offices of the Company at 3524
Hayden Avenue, Culver City, California.

     2.11 Real Property. The Company does not own any real property.

     2.12 Real Property Leases. Section 2.15(a)(iv) of the Disclosure Schedule
lists all real property leased or subleased to or by the Company and lists the
term of such lease, any extension and expansion options, and the rent payable
thereunder. The Company has delivered to the Buyer complete and accurate copies
of all leases and subleases (as amended to date). The Company has not assigned,
transferred, conveyed, mortgaged, deeded in trust or encumbered any interest in
the leasehold or subleasehold.

                                      -12-
<PAGE>

     2.13 Intellectual Property.

         (a) The Company owns or has the right to use all Intellectual Property
(as defined below) necessary (i) to use, manufacture, market and distribute (A)
the products manufactured, marketed, sold or licensed, and to provide the
services provided, and (B) those products or services under development
described in Section 2.13(a) of the Disclosure Schedule (in the case of products
or services so described in such Section 2.13(a), subject to obtaining standard
licenses for commercially available, off the shelf products) (together, the
"Customer Deliverables") or (ii) to operate the Company's internal systems that
are material to the business or operations of the Company, including, without
limitation, computer hardware systems, software applications and embedded
systems (the "Internal Systems"; the Intellectual Property owned by or licensed
to the Company and incorporated in or underlying the Customer Deliverables or
the Internal Systems is referred to herein as the "Company Intellectual
Property"). Each item of Company Intellectual Property will be owned or
available for use by the Surviving Corporation immediately following the Closing
on substantially identical terms and conditions as it was immediately prior to
the Closing. The Company has taken all reasonable measures to protect the
proprietary nature of each item of Company Intellectual Property, and to
maintain in confidence all trade secrets and confidential information that it
owns or uses. To the knowledge of the Company, (a) no other person or entity has
any rights to any of the Company Intellectual Property owned by the Company
(except pursuant to agreements or licenses specified in Section 2.13(c) of the
Disclosure Schedule), and (b) no other person or entity is infringing, violating
or misappropriating any of the Company Intellectual Property. For purposes of
this Agreement, "Intellectual Property" means all (i) patents and patent
applications, (ii) copyrights and registrations thereof, (iii) mask works and
registrations and applications for registration thereof, (iv) computer software,
data and documentation, (v) trade secrets and confidential business information,
whether patentable or unpatentable and whether or not reduced to practice,
know-how, manufacturing and production processes and techniques, research and
development information, copyrightable works, financial, marketing and business
data, pricing and cost information, business and marketing plans and customer
and supplier lists and information, (vi) trademarks, service marks, trade names,
domain names and applications and registrations therefor and (vii) other
proprietary rights relating to any of the foregoing. Section 2.13(a) of the
Disclosure Schedule lists each patent, patent application, copyright
registration or application therefor, mask work registration or application
therefor, and trademark, service mark and domain name registration or
application therefor of the Company.

         (b) To the Company's knowledge, none of the Customer Deliverables, or
the marketing, distribution, provision or use thereof, infringes or violates, or
constitutes a misappropriation of, any Intellectual Property rights of any
person or entity. To the Company's knowledge, none of the Internal Systems, or
the use thereof, infringes or violates, or constitutes a misappropriation of,
any Intellectual Property rights of any person or entity. Section 2.13(b) of the
Disclosure Schedule lists any complaint, claim or notice, or written threat
thereof, received by the Company alleging any such infringement, violation or
misappropriation; and the Company has provided to the Buyer complete and
accurate copies of all written documentation in the possession of the Company
relating to any such complaint, claim, notice or threat. The Company has
provided to the Buyer complete and accurate copies of all written documentation

                                      -13-
<PAGE>

in the Company's possession relating to claims or disputes known to the Company
concerning any Company Intellectual Property.

         (c) Section 2.13(c) of the Disclosure Schedule identifies each license
or other agreement (or type of license or other agreement) pursuant to which the
Company has licensed, distributed or otherwise granted any rights to any third
party with respect to, any Company Intellectual Property other than
non-exclusive licenses entered into in the Ordinary Course of Business in
substantially the terms as the licenses identified on, or as otherwise described
in, Section 2.13(c) of the Disclosure Schedule.

         (d) Section 2.13(d) of the Disclosure Schedule identifies each item of
Company Intellectual Property that is owned by a party other than the Company,
and the license or agreement pursuant to which the Company uses it (excluding
off-the-shelf software programs licensed by the Company pursuant to "shrink
wrap" or "click wrap" licenses).

         (e) The Company has not disclosed the source code for any of the
software owned by the Company (the "Software") to any person or entity, except
(i) to its employees, (ii) to consultants or agents pursuant to agreements
prohibiting the disclosure of the Software to third parties and protecting the
confidentiality thereof, or (iii) pursuant to the agreements listed in Section
2.13(e) of the Disclosure Schedule, and the Company has taken reasonable
measures to prevent disclosure of such source code to any third parties.

         (f) All of the copyrightable materials (including Software)
incorporated in or bundled with the Customer Deliverables have been created by
employees of the Company within the scope of their employment by the Company or
by independent contractors of the Company who have executed agreements expressly
assigning all right, title and interest in such copyrightable materials to the
Company. No portion of such copyrightable materials was jointly developed with
any third party.

         (g) To the knowledge of the Company, the Customer Deliverables
(excluding those under development) and the Internal Systems are free from
significant defects or programming errors and the Customer Deliverables
(excluding those under development) conform in all material respects to the
written documentation and specifications therefor.

     2.14 Year 2000 Compliance.

         (a) All of the Customer Deliverables currently being marketed,
distributed or licensed by the Company or which were marketed, distributed or
licensed by the Company since its inception, and to the Company's knowledge all
Internal Systems, are Year 2000 Compliant. The Company is not aware of any
failure to be Year 2000 Compliant of any third-party system that is material to
the business or operations of the Company, including without limitation any
system belonging to any of the Company's suppliers, service providers or
customers.

         (b) The Company has not provided any express guaranty or warranty for
any service or product or to the effect that such service or product is Year
2000 Compliant or has not been adversely affected by virtue of the arrival of
Year 2000.

                                      -14-
<PAGE>

         (c) For purposes of this Agreement, "Year 2000 Compliant" means that
the applicable system or item:

             (i) accurately receives, records, stores, provides, recognizes and
processes all date and time data from, during, into and between the twentieth
and twenty-first centuries, the years 1999 and 2000 and all leap years;

            (ii) accurately performs all date-dependent calculations and
operations (including, without limitation, mathematical operations, sorting,
comparing and reporting) from, during, into and between the twentieth and
twenty- first centuries, the years 1999 and 2000 and all leap years; and

           (iii) does not malfunction, cease to function or provide invalid or
incorrect results as a result of (x) the change of years from 1999 to 2000, (y)
date data, including date data which represents or references different
centuries, different dates during 1999 and 2000, or more than one century or (z)
the occurrence of any particular date; in each case without human intervention,
other than original data entry.

2.15  Contracts.

         (a) Section 2.15 of the Disclosure Schedule lists the following
agreements (written or oral) to which the Company is a party as of the date of
this Agreement:

          (i) any agreement (or group of related agreements) providing for
payments in excess of $50,000 per annum in the Ordinary Course of Business
(other than non-exclusive licenses entered into in the Ordinary Course of
Business on substantially the terms as the licensed identified on, or as
otherwise described in, Section 2.13(c) of the Disclosure Schedule) or $25,000
per annum not in the Ordinary Course of Business;

          (ii) any agreement (or group of related agreements) for the purchase
or sale of products or for the furnishing or receipt of services (A) which calls
for performance over a period of more than one year, (B) which involves more
than the sum of $50,000 per annum in the Ordinary Course of Business or $25,000
per annum not in the Ordinary Course of Business, or (C) in which the Company
has granted "most favored nation" pricing provisions or marketing or
distribution rights relating to any products or territory or has agreed to
purchase a minimum quantity of goods or services or has agreed to purchase goods
or services exclusively from a certain party;

          (iii) any agreement establishing a partnership or joint venture;

          (iv) any lease or sublease of real property;

          (v) any agreement (or group of related agreements) under which it has
created, incurred, assumed or guaranteed (or may create, incur, assume or
guarantee) indebtedness (including capitalized lease obligations) or under which
it has imposed (or may impose) a Security Interest on any of its assets,
tangible or intangible;

                                      -15-
<PAGE>

          (vi) any agreement concerning noncompetition;

          (vii) any employment or consulting agreement;

          (viii) any agreement with any officer, director or 5% or greater
shareholder of the Company or any affiliate (an "Affiliate"), as defined in Rule
12b-2 under the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), thereof;

          (ix) any agreement under which the consequences of a default or
termination would reasonably be expected to have a Company Material Adverse
Effect;

          (x) any agreement which contains any provisions requiring the Company
to indemnify any other party thereto (excluding indemnities contained in
agreements for the purchase, sale or license of products or services entered
into in the Ordinary Course of Business); and

          (xi) any other material agreement (or group of related agreements) not
entered into in the Ordinary Course of Business.

         (b) The Company has delivered to the Buyer a complete and accurate copy
of each agreement (as amended to date) listed in Section 2.13 or Section 2.15 of
the Disclosure Schedule. With respect to each agreement so listed: (i) the
agreement is legal, valid, binding and enforceable and in full force and effect;
(ii) the agreement will continue to be legal, valid, binding and enforceable and
in full force and effect immediately following the Closing in accordance with
the terms thereof as in effect immediately prior to the Closing; and (iii)
neither the Company nor, to the knowledge of the Company, any other party, is in
breach or violation of, or default under, any such agreement, and no event has
occurred which, after the giving of notice, with lapse of time, or otherwise,
would constitute a breach or default by the Company or, to the knowledge of the
Company, any other party under such contract.

         (c) There is no agreement (non-compete or otherwise), commitment,
judgment, injunction, order or decree to which the Company is a party or
otherwise binding upon the Company which prohibits or impairs any acquisition of
property (tangible or intangible) by the Company, or the conduct of business by
the Company or otherwise limits the freedom of the Company to engage in any line
of business or to compete with any person. Without limiting the generality of
the foregoing, the Company has not entered into any agreement under which the
Company is restricted from selling, licensing or otherwise distributing any of
its technology or products to or providing services to, customers or potential
customers or any class of customers, in any geographic area, during any period
of time or in any segment of the market.

     2.16 Powers of Attorney. There are no outstanding powers of attorney
executed on behalf of the Company.

     2.17 Insurance. Section 2.17 of the Disclosure Schedule lists each
insurance policy (including fire, theft, casualty, general liability, workers
compensation, business interruption, environmental, product liability and
automobile insurance policies and bond and surety arrangements) to which the
Company is a party. Such insurance policies are of the type and in

                                      -16-
<PAGE>

amounts reasonably believed by the Company to be prudent for organizations
conducting businesses or owning assets similar to those of the Company. There is
no material claim pending under any such policy as to which coverage has been
questioned, denied or disputed by the underwriter of such policy. All premiums
due and payable under all such policies have been paid, the Company is not
liable for retroactive premiums or similar payments, and the Company is in
compliance in all material respects with the terms of such policies. The Company
has no knowledge of any threatened termination of, or material premium increase
with respect to, any such policy.

     2.18 Litigation. There is no action, suit, proceeding, claim, arbitration
or investigation before any Governmental Entity or before any arbitrator (a
"Legal Proceeding") which is pending or has been threatened against the Company
in a writing delivered to the Company or otherwise to the Company's knowledge.

     2.19 Warranties. No product or service manufactured, sold, leased, licensed
or delivered by the Company is subject to any guaranty, warranty, right of
return, right of credit or other indemnity other than (i) the applicable
standard terms and conditions of sale, license or lease of the Company, which
are set forth in Section 2.19 of the Disclosure Schedule or are on terms
substantially consistent therewith; (ii) manufacturers' warranties for which the
Company does not have any liability; and (iii) warranties implied under law.

     2.20 Employees.

         (a) Section 2.20 of the Disclosure Schedule contains a list of all
employees of the Company, along with the position and the annual rate of
compensation of each such person. Each employee has entered into a
confidentiality and assignment of inventions agreement with the Company,
substantially in the form previously delivered to the Buyer. Each such agreement
(i) is legal, valid, binding and enforceable and in full force and effect; and
(ii) will continue to be legal, valid, binding and enforceable and in full force
and effect immediately following the Closing in accordance with the terms
thereof as in effect immediately prior to the Closing. Neither the Company nor,
to the knowledge of the Company, any other party, is in breach or violation of,
or default under, any such agreement and no event has occurred which, after the
giving of notice, with the lapse of time, or otherwise, would constitute a
breach or default by the Company or, to the knowledge of the Company, any other
party to such agreement. To the knowledge of the Company, as of the date hereof
no officer or member of the development staff, and no material number of other
employees, has any plans to terminate employment with the Company.

         (b) The Company is not party to or bound by any collective bargaining
agreement, nor has any of them experienced any strikes, grievances, claims of
unfair labor practices or other collective bargaining disputes. The Company has
no knowledge of any organizational effort made or threatened, either currently
or within the past two years, by or on behalf of any labor union with respect to
employees of the Company.

                                      -17-
<PAGE>

     2.21 Employee Benefits.

         (a) Section 2.21(a) of the Disclosure Schedule contains a complete and
accurate list of all Employee Benefit Plans (as defined below) maintained, or
contributed to, by the Company. Complete and accurate copies of all Employee
Benefit Plans have been delivered to the Buyer. The Company has complied in all
material respects, in the administration and operation of each Employee Benefit
Plan, with the terms of such Plan and the requirements of applicable law
(including without limitation the Employee Retirement Income Security Act of
1974, as amended ("ERISA"), and the Code and the regulations thereunder). The
Company has no monetary liability in excess of $25,000 under any Employee
Benefit Plan, except for those set forth on the Most Recent Balance Sheet or
those that have arisen since the date of the Most Recent Balance Sheet in the
Ordinary Course of Business. "Employee Benefit Plan" means any "employee pension
benefit plan" (as defined in Section 3(2) of ERISA), any "employee welfare
benefit plan" (as defined in Section 3(1) of ERISA), and any other written or
oral plan, agreement or arrangement involving direct or indirect compensation,
including without limitation insurance coverage, severance benefits, disability
benefits, deferred compensation, bonuses, stock options, stock purchase, phantom
stock, stock appreciation or other forms of incentive compensation or
post-retirement compensation.

         (b) All the Employee Benefit Plans that are intended to be qualified
under Section 401(a) of the Code have received determination letters from the
Internal Revenue Service to the effect that such Employee Benefit Plans are
qualified and the plans and the trusts related thereto are exempt from federal
income taxes under Sections 401(a) and 501(a), respectively, of the Code, no
such determination letter has been revoked and revocation has not been
threatened, and no such Employee Benefit Plan has been amended or operated since
the date of its most recent determination letter or application therefor in any
respect, and no act or omission has occurred, that would adversely affect its
qualification or materially increase its cost. Each Employee Benefit Plan which
is required to satisfy Section 401(k)(3) or Section 401(m)(2) of the Code, and
satisfies the requirements of, Section 401(k)(3) and Section 401(m)(2) of the
Code for each plan year ending prior to the Closing Date.

         (c) There are no unfunded obligations under any Employee Benefit Plan
providing benefits after termination of employment to any employee of the
Company (or to any beneficiary of any such employee), including but not limited
to retiree health coverage and deferred compensation, but excluding continuation
of health coverage required to be continued under Section 4980B of the Code or
other applicable law and insurance conversion privileges under state law. The
assets of each Employee Benefit Plan which is funded are reported at their fair
market value on the books and records of such Employee Benefit Plan.

         (d) Each Employee Benefit Plan is amendable and terminable unilaterally
by the Company at any time without liability to the Company as a result thereof
and no Employee Benefit Plan, plan documentation or agreement, summary plan
description or other written communication distributed generally to employees by
its terms prohibits the Company from amending or terminating any such Employee
Benefit Plan.

                                      -18-
<PAGE>

         (e) Section 2.21(e) of the Disclosure Schedule discloses each: (i)
agreement with any shareholder, consultant, director, officer or other employee
of the Company (A) the benefits of which are contingent, or the terms of which
are materially altered, upon the occurrence of a transaction involving the
Company of the nature of any of the transactions contemplated by this Agreement,
(B) providing any term of employment or compensation guarantee or (C) providing
severance benefits or other benefits after the termination of employment of such
director, officer or employee; (ii) agreement, plan or arrangement under which
any person may receive payments from the Company that may be subject to the tax
imposed by Section 4999 of the Code or included in the determination of such
person's "parachute payment" under Section 280G of the Code; and (iii) agreement
or plan binding the Company, including without limitation any stock option plan,
stock appreciation right plan, restricted stock plan, stock purchase plan,
severance benefit plan or Employee Benefit Plan, any of the benefits of which
will be increased, or the vesting of the benefits of which will be accelerated,
by the occurrence of any of the transactions contemplated by this Agreement or
the value of any of the benefits of which will be calculated on the basis of any
of the transactions contemplated by this Agreement.

         (f) Section 2.21(f) of the Disclosure Schedule sets forth the policy of
the Company with respect to accrued vacation, accrued sick time and earned
time-off and the amount of such liabilities as of January 31, 2000.

2.22  Environmental Matters.

         (a) The Company has complied in all material respects with all
applicable Environmental Laws (as defined below). There is no pending or, to the
knowledge of the Company, threatened civil or criminal litigation, written
notice of violation, formal administrative proceeding, or investigation, inquiry
or information request by any Governmental Entity, relating to any Environmental
Law involving the Company. For purposes of this Agreement, "Environmental Law"
means any federal, state or local law, statute, rule or regulation or the common
law relating to the environment or occupational health and safety, including
without limitation any statute, regulation, administrative decision or order
pertaining to (i) treatment, storage, disposal, generation and transportation of
industrial, toxic or hazardous materials or substances or solid or hazardous
waste; (ii) air, water and noise pollution; (iii) groundwater and soil
contamination; (iv) the release or threatened release into the environment of
industrial, toxic or hazardous materials or substances, or solid or hazardous
waste, including without limitation emissions, discharges, injections, spills,
escapes or dumping of pollutants, contaminants or chemicals; (v) the protection
of wild life, marine life and wetlands, including without limitation all
endangered and threatened species; (vi) storage tanks, vessels, containers,
abandoned or discarded barrels, and other closed receptacles; (vii) health and
safety of employees and other persons; and (viii) manufacturing, processing,
using, distributing, treating, storing, disposing, transporting or handling of
materials regulated under any law as pollutants, contaminants, toxic or
hazardous materials or substances or oil or petroleum products or solid or
hazardous waste. As used above, the terms "release" and "environment" shall have
the meaning set forth in the Comprehensive Environmental Response, Compensation
and Liability Act of 1980, as amended ("CERCLA").

                                      -19-
<PAGE>

         (b) There have been no releases of any Materials of Environmental
Concern (as defined below) into the environment at any parcel of real property
or any facility formerly or currently owned, operated or controlled by the
Company in violation of any Environmental Law. With respect to any such releases
of Materials of Environmental Concern, the Company has given all required
notices to Governmental Entities (copies of which have been provided to the
Buyer). The Company is not aware of any releases of Materials of Environmental
Concern at parcels of real property or facilities other than those owned,
operated or controlled by the Company that could reasonably be expected to have
a material impact on the real property or facilities owned, operated or
controlled by the Company. For purposes of this Agreement, "Materials of
Environmental Concern" means any chemicals, pollutants or contaminants,
hazardous substances (as such term is defined under CERCLA), solid wastes and
hazardous wastes (as such terms are defined under the Resource Conservation and
Recovery Act), toxic materials, oil or petroleum and petroleum products or any
other material subject to regulation under any Environmental Law.

         (c) Set forth in Section 2.22(c) of the Disclosure Schedule is a list
of all documents (whether in hard copy or electronic form) that contain any
environmental reports, investigations and audits relating to premises currently
or previously owned or operated by the Company (whether conducted by or on
behalf of the Company or a third party, and whether done at the initiative of
the Company or directed by a Governmental Entity or other third party) which the
Company has possession of or access to. A complete and accurate copy of each
such document has been provided to the Buyer.

     2.23 Legal Compliance. The Company, and the conduct and operations of its
business, are each in compliance in all material respects with each applicable
law (including rules and regulations thereunder) of any federal, state, local or
foreign government, or any Governmental Entity.

     2.24 Suppliers. Section 2.24 of the Disclosure Schedule sets forth a list
of each supplier that is the sole supplier of any significant product or service
to the Company. No such supplier has indicated within the past year that it will
stop, or decrease the rate of, supplying products or services to the Company. No
unfilled customer order or commitment obligating the Company to process,
manufacture or deliver products or perform services is currently expected to
result in a loss to the Company upon completion of performance, except for any
such orders or commitments that may be canceled by the Company unilaterally
without further obligation upon 30 days' or less notice.

     2.25 Permits. Section 2.25 of the Disclosure Schedule sets forth a list of
all material permits, licenses, registrations, certificates, orders or approvals
from any Governmental Entity (including without limitation those issued or
required under Environmental Laws and those relating to the occupancy or use of
owned or leased real property) ("Permits") issued to or held by the Company.
Such listed Permits are the only Permits that are required for the Company to
conduct its business as presently conducted or as proposed to be conducted,
except for those the absence of which, individually or in the aggregate, have
not had and would not reasonably be expected to have a Company Material Adverse
Effect. Each such Permit is in full force and effect and, to the knowledge of
the Company, no suspension or cancellation of such Permit is

                                      -20-
<PAGE>

threatened. Each such Permit will continue in full force and effect immediately
following the Closing.

     2.26 Certain Business Relationships With Affiliates. No Affiliate of the
Company (a) owns any property or right, tangible or intangible, which is used in
the business of the Company, (b) has any claim or cause of action against the
Company, or (c) owes any money to, or is owed any money by, the Company other
than compensation for services rendered as an officer or director. Section 2.26
of the Disclosure Schedule describes any transactions or relationships between
the Company and any Affiliate thereof which have occurred or existed since the
Company's inception.

     2.27 Brokers' Fees. Except for the fee payable to Broadview International
L.L.C. pursuant to the letter agreement dated December 30, 2000 (a true and
complete copy of which, insofar as it relates to the Buyer or the transactions
contemplated hereby, has been provided to the Buyer), the Company does not have
any liability or obligation to pay any fees or commissions to any broker, finder
or agent with respect to the transactions contemplated by this Agreement.

     2.28 Books and Records. The minute books and other similar records of the
Company contain complete and accurate records of all actions taken at any
meetings of the Company's shareholders, Board of Directors or any committee
thereof and of all written consents executed in lieu of the holding of any such
meeting. The books and records of the Company accurately reflect in all material
respects the assets, liabilities, business, financial condition and results of
operations of the Company and have been maintained in accordance with reasonable
business and bookkeeping practices.

     2.29 Proxy Statement. The information in or accompanying the proxy
statement (except for information supplied by the Buyer for inclusion therein,
as to which the Company makes no representation) to be sent to the Company
Shareholders in connection with the meeting (the "Company Meeting") of the
Company Shareholders to consider this Agreement and the Merger (the "Proxy
Statement"), shall not, on the date that the Proxy Statement is first mailed to
the Company Shareholders, at the time of the Company Meeting and at the
Effective Time, contain any statement which, at such time and in light of the
circumstances under which it shall be made, is false or misleading with respect
to any material fact, or omit to state any material fact necessary in order to
make the statements made in the Proxy Statement not false or misleading, or omit
to state any material fact necessary to correct any statement in any earlier
communication with respect to the solicitation of proxies for the Company
Meeting which has become false or misleading. If at any time prior to the
Effective Time any event relating to the Company or any of its Affiliates,
officers or directors should be discovered by the Company which should be set
forth in an amendment to the Proxy Statement, the Company shall promptly inform
the Buyer.

     2.30 Disclosure. The representations and warranties by the Company
contained in this Agreement, and the statements contained in the Disclosure
Schedule, do not contain any untrue statement of a material fact or omit to
state any material fact necessary, in light of the circumstances under which
they were made, in order to make the statements herein or therein not

                                      -21-
<PAGE>

misleading. The Company has delivered to the Buyer true and complete copies of
all documents which are referred to in Sections 2.12, 2.13, 2.15 and 2.21 or in
the Disclosure Schedule.

                                  ARTICLE III.
                   REPRESENTATIONS AND WARRANTIES OF THE BUYER
                          AND THE TRANSITORY SUBSIDIARY

     Each of the Buyer and the Transitory Subsidiary represents and warrants to
the Company as follows:

     3.1 Organization, Qualification and Corporate Power. Each of the Buyer and
the Transitory Subsidiary is a corporation duly organized, validly existing and
in good standing under the laws of the state of its incorporation. The Buyer is
duly qualified to conduct business and is in corporate and tax good standing
under the laws of each jurisdiction in which the nature of its businesses or the
ownership or leasing of its properties requires such qualification, except where
the failure to be so qualified or in good standing would not have a Buyer
Material Adverse Effect (as defined below). The Buyer has all requisite
corporate power and authority to carry on the businesses in which it is engaged
and to own and use the properties owned and used by it. The Buyer has furnished
or made available to the Company complete and accurate copies of its Certificate
of Incorporation and By-laws. For purposes of this Agreement, "Buyer Material
Adverse Effect" means a material adverse effect on the assets, business,
condition (financial or otherwise), results of operations or future prospects of
the Buyer and its subsidiaries, taken as a whole, other than any effect
primarily and directly resulting from (a) the execution of this Agreement or the
announcement or pendency of transactions contemplated hereby or (b) conditions
generally effecting the Buyer's industry as a whole; provided, that a drop in
the Buyer's stock price shall not, in and of itself, constitute such a material
adverse effect.

     3.2 Capitalization. The authorized capital stock of the Buyer consists of
(a) 75,000,000 shares of Buyer Common Stock, of which 28,048,251 shares were
issued and outstanding of record as of February 14, 2000, and (b) 10,000,000
shares of Preferred Stock, $.01 par value per share, of which no shares were
issued or outstanding of record as of February 14, 2000. All of the issued and
outstanding shares of Buyer Common Stock are duly authorized, validly issued,
fully paid, nonassessable and free of all preemptive rights. All of the Merger
Shares will be, when issued in accordance with this Agreement, duly authorized,
validly issued, fully paid, nonassessable and free of all preemptive rights.

     3.3 Authorization of Transaction. Each of the Buyer and the Transitory
Subsidiary has all requisite power and authority to execute and deliver this
Agreement and (in the case of the Buyer) the Escrow Agreement and to perform its
obligations hereunder and thereunder. The execution and delivery by the Buyer
and the Transitory Subsidiary of this Agreement and (in the case of the Buyer)
the Escrow Agreement and the consummation by the Buyer and the Transitory
Subsidiary of the transactions contemplated hereby and thereby have been duly
and validly authorized by all necessary corporate action on the part of the
Buyer and Transitory Subsidiary, respectively. This Agreement has been duly and
validly executed and delivered by

                                      -22-
<PAGE>

the Buyer and the Transitory Subsidiary and constitutes a valid and binding
obligation of the Buyer and the Transitory Subsidiary, enforceable against them
in accordance with its terms.

     3.4 Noncontravention. Subject to compliance with the applicable
requirements of the Securities Act and any applicable state securities laws and
the filing of the Certificate of Merger as required by the California General
Corporation Law, neither the execution and delivery by the Buyer or the
Transitory Subsidiary of this Agreement or (in the case of the Buyer) the Escrow
Agreement, nor the consummation by the Buyer or the Transitory Subsidiary of the
transactions contemplated hereby or thereby, will (a) conflict with or violate
any provision of the charter or By-laws of the Buyer or the Transitory
Subsidiary, (b) require on the part of the Buyer or the Transitory Subsidiary
any filing with, or permit, authorization, consent or approval of, any
Governmental Entity, (c) conflict with, result in breach of, constitute (with or
without due notice or lapse of time or both) a default under, result in the
acceleration of obligations under, create in any party any right to terminate,
modify or cancel, or require any notice, consent or waiver under, any contract
or instrument to which the Buyer or the Transitory Subsidiary is a party or by
which either is bound or to which any of their assets are subject, or (d)
violate any order, writ, injunction, decree, statute, rule or regulation
applicable to the Buyer or the Transitory Subsidiary or any of their properties
or assets.

     3.5 Reports and Financial Statements. The Buyer has previously furnished or
made available to the Company complete and accurate copies, as amended or
supplemented, of its (a) Prospectus dated November 3, 1999 (as filed with the
Securities and Exchange Commission (the "SEC") pursuant to Rule 424 under the
Securities Act), and (b) all other reports filed by the Buyer under Section 13
or subsections (a) or (c) of Section 14 of the Exchange Act with the SEC since
November 3, 1999 (such reports are collectively referred to herein as the "Buyer
Reports"). The Buyer Reports constitute all of the documents required to be
filed by the Buyer under Section 13 or subsections (a) or (c) of Section 14 of
the Exchange Act with the SEC from November 3, 1999 through the date of this
Agreement. The Buyer Reports filed prior to the date of this Agreement complied,
and the Buyer reports filed after the date of this Agreement will comply, in all
material respects with the requirements of the Exchange Act and the rules and
regulations thereunder when filed. As of their respective dates the Buyer
Reports did not, and as of the date hereof and as of the Closing Date the Buyer
Reports, taken as a whole, do not and will not (except for disclosure relating
to the transactions contemplated hereby and the financial results for the Buyer
for the year ended December 31, 1999 as disclosed to the Company prior to the
date hereof) contain any untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not
misleading. The audited financial statements and unaudited interim financial
statements of the Buyer included in the Buyer Reports (i) complied as to form in
all material respects with applicable accounting requirements and the published
rules and regulations of the SEC with respect thereto when filed, (ii) were
prepared in accordance with GAAP applied on a consistent basis throughout the
periods covered thereby (except as may be indicated therein or in the notes
thereto, and in the case of quarterly financial statements, as permitted by Form
10-Q under the Exchange Act), (iii) fairly present the consolidated financial
condition, results of operations and cash flows of the Buyer as of the
respective dates thereof and for the periods referred to therein, and (iv) are
consistent with the books and records of the Buyer.

                                      -23-
<PAGE>

     3.6 Interim Operations of the Transitory Subsidiary. The Transitory
Subsidiary was formed solely for the purpose of engaging in the transactions
contemplated by this Agreement and has engaged in no business activities other
than as contemplated by this Agreement.

     3.7 Brokers' Fees. Except for any fee that may be payable to Donaldson,
Lufkin & Jenrette Securities Corporation, neither the Buyer nor the Transitory
Subsidiary has any liability or obligation to pay any fees or commissions to any
broker, finder or agent with respect to the transactions contemplated by this
Agreement.

     3.8 Proxy Statement. The information to be supplied by the Buyer for
inclusion in the Proxy Statement shall not, on the date that the Proxy Statement
is first mailed to the Company Shareholders, at the time of the Company Meeting
and at the Effective Time, contain any statement which, at such time and in
light of the circumstances under which it shall be made, is false or misleading
with respect to any material fact, or omit to state any material fact necessary
in order to make the statements made in the Proxy Statement not false or
misleading, or omit to state any material fact necessary to correct any
statement in any earlier communication with respect to the solicitation of
proxies for the Company Meeting which has become false or misleading. If at any
time prior to the Effective Time any event relating to the Buyer or any of its
Affiliates, officers or directors should be discovered by the Buyer which should
be set forth in an amendment to the Proxy Statement, the Buyer shall promptly
inform the Company.

     3.9 Absence of Certain Changes. Since September 30, 1999, there has
occurred no event or development which has had, or could reasonably be expected
to have in the future, a Buyer Material Adverse Effect.

     3.10 Disclosure. The representations and warranties by the Buyer or the
Transitory Subsidiary contained in this Agreement contains any untrue statement
of a material fact or omit to state any material fact necessary, in light of the
circumstances under which they were made, in order to make the statements herein
or therein not misleading.

                                   ARTICLE IV.
                                    COVENANTS

     4.1 Closing Efforts. Each of the Parties shall use its best efforts, to the
extent commercially reasonable ("Reasonable Best Efforts"), to take all actions
and to do all things necessary, proper or advisable to consummate the
transactions contemplated by this Agreement, including without limitation using
its Reasonable Best Efforts to ensure that (i) its representations and
warranties remain true and correct in all material respects through the Closing
Date and (ii) the conditions to the obligations of the other Parties to
consummate the Merger are satisfied.

     4.2 Governmental and Third-Party Notices and Consents.

         (a) Each Party shall use its Reasonable Best Efforts to obtain, at its
expense, all waivers, permits, consents, approvals or other authorizations from
Governmental Entities, and to effect all registrations, filings and notices with
or to Governmental Entities, as may be

                                      -24-
<PAGE>

required for such Party to consummate the transactions contemplated by this
Agreement and to otherwise comply with all applicable laws and regulations in
connection with the consummation of the transactions contemplated by this
Agreement.

         (b) The Company shall use its Reasonable Best Efforts to obtain, at its
expense, all such waivers, consents or approvals from third parties, and to give
all such notices to third parties, as are required to be listed in Section 2.4
of the Disclosure Schedule.

     4.3 Shareholder Approval.

         (a) The Company shall use its Reasonable Best Efforts to obtain, as
promptly as practicable, the Requisite Shareholder Approval at the Company
Meeting, all in accordance with the applicable requirements of the California
General Corporation Law. Promptly after the date hereof, Company will take all
action necessary in accordance with the California General Corporation Law to
convene the Company Meeting to be held as promptly as practicable, and in any
event (to the extent permissible under applicable law) within 15 days after the
date hereof, for the purpose of voting upon this Agreement and the Merger. The
Company will use its Reasonable Best Efforts to solicit from its shareholders
proxies in favor of the adoption and approval of this Agreement and the approval
of the Merger and will take all other action necessary or advisable to secure
the Requisite Shareholder Vote. Notwithstanding anything to the contrary
contained in this Agreement, the Company may adjourn or postpone the Company
Meeting to the extent necessary to ensure that any necessary supplement or
amendment to the Proxy Statement is provided to the Company Shareholders in
advance of a vote on the Merger and this Agreement. The Company shall ensure
that the Company Meeting is called, noticed, convened, held and conducted, and
that all proxies solicited by the Company in connection with the Company Meeting
are solicited, in compliance with the California General Corporation Law and all
other applicable legal requirements.

         (b) In connection with the Company Meeting, the Company shall provide
to its shareholders the Proxy Statement which shall include (A) a summary of the
Merger and this Agreement (which summary shall include a summary of the terms
relating to the indemnification obligations of the Company Shareholders, the
escrow arrangements and the authority of the Indemnification Representatives,
and a statement that the adoption of this Agreement by the shareholders of the
Company shall constitute approval of such terms), (B) all of the information
required by Rule 502(b)(2) of Regulation D under the Securities Act and (C) a
statement that appraisal rights are available for the Company Shares pursuant to
Chapter 13 of the California General Corporation Law and a copy of such Chapter
13. The Buyer agrees to cooperate with the Company in the preparation of the
Proxy Statement. The Company agrees not to distribute the Proxy Statement until
the Buyer has had a reasonable opportunity to review and comment on the Proxy
Statement and the Proxy Statement has been approved by the Buyer (which approval
may not be unreasonably withheld or delayed).

         (c) The Company, acting through its Board of Directors, shall include
in the Proxy Statement the unanimous recommendation of its Board of Directors
that the shareholders of the Company vote in favor of the adoption of this
Agreement and the approval of the Merger.

                                      -25-
<PAGE>

         (d) The Company shall ensure that the Proxy Statement does not contain
any untrue statement of a material fact or omit to state a material fact
necessary in order to make the statements made, in light of the circumstances
under which they were made, not misleading (provided that the Company shall not
be responsible for the accuracy or completeness of any information furnished by
the Buyer in writing for inclusion in the Proxy Statement).

         (e) The Buyer shall ensure that any information furnished by the Buyer
to the Company in writing for inclusion in the Proxy Statement does not contain
any untrue statement of a material fact or omit to state a material fact
necessary in order to make the statements made, in light of the circumstances
under which they were made, not misleading.

         (f) Simultaneous with the execution of this Agreement, the Company
Shareholders set forth in Schedule I hereto shall each have executed a Voting
Agreement and Irrevocable Proxy in the form attached hereto as Exhibit B.

     4.4 Operation of Business. Except as contemplated by this Agreement, during
the period from the date of this Agreement to the Effective Time, the Company
shall conduct its operations in the Ordinary Course of Business and in
compliance in all material respects with all applicable laws and regulations
and, to the extent consistent therewith, use its Reasonable Best Efforts to
preserve intact its current business organization, keep its physical assets in
good working condition, keep available the services of its current officers and
employees and preserve its relationships with customers, suppliers and others
having business dealings with it to the end that its goodwill and ongoing
business shall not be impaired in any material respect. Without limiting the
generality of the foregoing, prior to the Effective Time, the Company shall not,
without the written consent of the Buyer:

         (a) except as set forth in Section 4.4(a) of the Disclosure Schedule,
issue or sell, or redeem or repurchase, any stock or other securities of the
Company or any rights, warrants or options to acquire any such stock or other
securities (except pursuant to the exercise of Options or Warrants outstanding
on the date hereof and except for the issuance of Retention Options (as defined
below and as set forth in Section 4.4(a) of the Disclosure Schedule)), or amend
any of the terms of (including without limitation the vesting of) any such
Options or Warrants;

         (b) split, combine or reclassify any shares of its capital stock;
declare, set aside or pay any dividend or other distribution (whether in cash,
stock or property or any combination thereof) in respect of its capital stock;

         (c) create, incur or assume any indebtedness (including obligations in
respect of capital leases) except for the borrowing of up to $225,000 from
Silicon Valley Bank under existing credit facilities if the Effective Time shall
not have occurred on or before February 29, 2000; assume, guarantee, endorse or
otherwise become liable or responsible (whether directly, contingently or
otherwise) for the obligations of any other person or entity; or make any loans,
advances or capital contributions to, or investments in, any other person or
entity other than advances to employees and investments in money market
instruments made in the Ordinary Course of Business;

                                      -26-
<PAGE>

         (d) except for the grant of Retention Options or as otherwise set forth
in Section 4.4(d) of the Disclosure Schedule, hire any new employees, enter
into, adopt or amend any Employee Benefit Plan or any employment or severance
agreement or arrangement of the type described in Section 2.21(e) or increase in
any manner the compensation or fringe benefits of, or modify the employment
terms of, its directors, officers or employees, generally or individually, or
pay any bonus or other benefit to its directors, officers or employees (except
for existing payment obligations listed in Section 2.20 of the Disclosure
Schedule);

         (e) acquire, sell, lease, license or dispose of any assets or property
(including without limitation any shares or other equity interests in or
securities of any corporation, partnership, association or other business
organization or division thereof), other than purchases, licenses and sales of
assets in the Ordinary Course of Business;

         (f) mortgage or pledge any of its property or assets or subject any
such property or assets to any Security Interest;

         (g) discharge or satisfy any Security Interest or pay any obligation or
liability other than in the Ordinary Course of Business;

         (h) amend its charter, by-laws or other organizational documents;

         (i) change in any material respect its accounting methods, principles
or practices, except insofar as may be required by a generally applicable change
in GAAP;

         (j) amend, terminate, take or omit to take any action that would
constitute a violation of or default under, or waive any rights under, any
material contract or agreement or enter into any material contract or agreement
other than in the Ordinary Course of Business;

         (k) make or commit to make any capital expenditure in excess of $2,000
per item or $10,000 in the aggregate;

         (l) institute or settle any Legal Proceeding;

         (m) take any action or fail to take any action permitted by this
Agreement with the knowledge that such action or failure to take action would
result in (i) any of the representations and warranties of the Company set forth
in this Agreement becoming untrue or (ii) any of the conditions to the Merger
set forth in Article V not being satisfied; or

         (n) agree in writing or otherwise to take any of the foregoing actions.

     4.5 Access to Information. The Company shall permit representatives of the
Buyer to have full access (at all reasonable times, and in a manner so as not to
interfere with the normal business operations of the Company) to all premises,
properties, financial and accounting records, contracts, other records and
documents, and personnel, of or pertaining to the Company.

                                      -27-
<PAGE>

     4.6 Notice of Breaches.

         (a) From the date of this Agreement until the Effective Time, the
Company shall promptly deliver to the Buyer supplemental information concerning
events or circumstances occurring subsequent to the date hereof which would
render any representation, warranty or statement in this Agreement or the
Disclosure Schedule inaccurate or incomplete at any time after the date of this
Agreement until the Closing Date. No such supplemental information shall be
deemed to cure any misrepresentation or breach of warranty or constitute an
amendment of any representation, warranty or statement in this Agreement or the
Disclosure Schedule.

         (b) From the date of this Agreement until the Effective Time, the Buyer
shall promptly deliver to the Company supplemental information concerning events
or circumstances occurring subsequent to the date hereof which would render any
representation or warranty in this Agreement inaccurate or incomplete at any
time after the date of this Agreement until the Closing Date. No such
supplemental information shall be deemed to cure any misrepresentation or breach
of warranty or constitute an amendment of any representation or warranty in this
Agreement.

     4.7 Exclusivity.

         (a) The Company shall not, and the Company shall require each of its
officers, directors, employees, representatives and agents not to, directly or
indirectly, (i) initiate, solicit, encourage or otherwise facilitate any
inquiry, proposal, offer or discussion with any party (other than the Buyer)
concerning any merger, reorganization, consolidation, recapitalization, business
combination, liquidation, dissolution, share exchange, sale of stock (other than
discussions after March 15, 2000 with venture capitalists (or similar investors)
with respect to the issuance of convertible preferred stock that, if issued,
would constitute less than 35% of the outstanding capital stock of the Company),
sale of material assets or similar business transaction involving the Company or
any division of the Company, (ii) furnish any non-public information concerning
the business, properties or assets of the Company or any division of the Company
to any party (other than the Buyer) or (iii) engage in discussions or
negotiations with any party (other than the Buyer) concerning any such
transaction.

         (b) The Company shall immediately notify any party with which
discussions or negotiations of the nature described in paragraph (a) above were
pending that the Company is terminating such discussions or negotiations. If the
Company receives any inquiry, proposal or offer of the nature described in
paragraph (a) above, the Company shall, within one business day after such
receipt, notify the Buyer of such inquiry, proposal or offer, including the
identity of the other party and the terms of such inquiry, proposal or offer.

     4.8 Expenses. Except as set forth in Article VI and the Escrow Agreement,
each of the Parties shall bear its own costs and expenses (including legal fees
and expenses) incurred in connection with this Agreement and the transactions
contemplated hereby; provided, however, that if the Merger is consummated, the
Buyer and Surviving Corporation shall not be obligated to pay more than an
aggregate of $2,000,000 in costs and expenses (including without limitation

                                      -28-
<PAGE>

legal, accounting and financial advisor fees) incurred by the Company in
connection with the Merger ("Third Party Expenses") and any such Third Party
Expenses incurred in excess of such amounts shall be subject to the
indemnification provisions of Article VI hereof.

     4.9 [Intentionally Omitted].

     4.10 Listing of Merger Shares. The Buyer shall have the Merger Shares
approved for quotation on the Nasdaq National Market subject only to official
notice of issuance.

     4.11 S-8 Registration. Not later than thirty (30) days after the Effective
Time, the Buyer agrees to file, if available for use by the Buyer, with the SEC
a registration statement on Form S-8 registering a number of shares of Buyer
Common Stock equal to the number of shares of Buyer Common Stock issuable upon
the exercise of all Options assumed by the Buyer pursuant to Section 1.8(a)
hereof.

     4.12 Retention Options. Prior to the Effective Time, the Company shall
issue to the persons listed on Section 4.4(b) of the Disclosure Schedule options
to acquire the number of Common Shares at the exercise price indicated thereon
(the "Retention Options") provided, that the form of the option agreement
governing such Retention Options shall have been delivered to the Buyer prior to
being furnished to such person and such agreement shall provide for vesting over
a four year period commencing on the first anniversary of the Effective Time,
shall provide that the Merger shall not constitute a "Corporate Transaction" for
purposes of Section 17 of the Option Plan and shall otherwise be reasonably
satisfactory to the Buyer.

     4.13 Employee Benefits. The Buyer will have no obligation to retain any
employee or group of employees of the Company following the Effective Time. As
soon as practicable after the execution of this Agreement, the Company and the
Buyer shall confer and work together in good faith to agree upon mutually
acceptable employee benefit and compensation arrangements (and terminate Company
employee plans immediately prior to the Effective Time, if appropriate) so as to
provide benefits to Company employees initially upon the Merger which are
generally equivalent to those being provided to employees of Company immediately
preceding the Effective Time, as well as to determine appropriate termination
benefits for Company employees generally and certain members of Company
management in particular, in addition to any and all severance, separation,
retention and salary continuation plans, programs or arrangements disclosed on
the Company Disclosure Schedule. Continuous employment with the Company or its
subsidiaries shall be credited to Company employees who become Buyer employees
for all purposes of eligibility and vesting of Benefits (to the extent permitted
by applicable law), but not for purposes of accrual of benefits.

     4.14 Indemnification. For a period of three years from and after the
Effective Time, the Buyer will, or will cause the Surviving Corporation to,
fulfill and honor in all respects the indemnification obligations of the Company
to its directors and officers under the articles of incorporation and by-laws as
in effect on the date hereof, except that the Buyer shall treat its assets as
the Company's assets for purposes of fulfilling its obligations under this
Section 4.14.

                                      -29-
<PAGE>

                                   ARTICLE V.
                      CONDITIONS TO CONSUMMATION OF MERGER

     5.1 Conditions to Each Party's Obligations. The respective obligations of
each Party to consummate the Merger are subject to the satisfaction of the
following conditions:

         (a) this Agreement and the Merger shall have received the Requisite
Shareholder Approval;

         (b) no Governmental Entity shall have enacted, issued, promulgated,
enforced or entered any statute, rule, regulation, executive order, decree,
injunction or other order (whether temporary, preliminary or permanent) which is
in effect and which has the effect of making the Merger illegal or otherwise
prohibiting consummation of the Merger;

         (c) no temporary restraining order, preliminary or permanent injunction
or other order issued by any court of competent jurisdiction or other legal
restraint or prohibition preventing the consummation of the Merger shall be in
effect, nor shall any proceeding brought by an administrative agency or
commission or other governmental authority or instrumentality, domestic or
foreign, seeking any of the foregoing be pending; and

         (d) approvals from any court, administrative agency or commission or
other federal, state, county, local or other foreign governmental authority,
instrumentality, agency or commission that are required to consummate the Merger
shall have been timely obtained.

     5.2 Conditions to Obligations of the Buyer and the Transitory Subsidiary.
The obligation of each of the Buyer and the Transitory Subsidiary to consummate
the Merger is subject to the satisfaction (or waiver by the Buyer) of the
following additional conditions:

         (a) the Dissenting Shares, if any, shall constitute less than 5% of the
outstanding Company Shares;

         (b) there shall not be more than 30 Company Shareholders that are not
"accredited investors" as that term is defined in Rule 501 promulgated by the
SEC pursuant to the Securities Act;

         (c) the Company shall have obtained (and shall have provided copies
thereof to the Buyer) all of the waivers, permits, consents, approvals or other
authorizations, and effected all of the registrations, filings and notices,
referred to in Section 5.2 to the Disclosure Schedule which are required on the
part of the Company;

         (d) the representations and warranties of the Company contained in this
Agreement shall have been true and correct as of the date of this Agreement and
as of the Effective Time except (i) to the extent that the failure of such
representations and warranties to be true and correct in each case or in the
aggregate does not constitute and could not reasonably be expected to constitute
in the future a Company Material Adverse Effect, (ii) for changes contemplated
by this Agreement and (iii) for those representations and warranties which
address matters only as of the date of this Agreement or any other particular
date (which shall have been

                                      -30-
<PAGE>

true and correct as of such particular date except to the extent that the
failure of such representations and warranties to be true and correct as of such
particular date does not, or could not reasonably be expected in the future to,
constitute a Company Material Adverse Effect) (it being understood that, for
purposes of determining the accuracy of such representations and warranties all
"Material Adverse Effect" qualifications and other qualifications based on the
word "material" or concepts of materiality contained in such representations and
warranties shall be disregarded);

         (e) the Company shall have performed or complied in all material
respects with its agreements and covenants required to be performed or complied
with under this Agreement as of or prior to the Effective Time;

         (f) no Legal Proceeding shall be pending or threatened wherein an
unfavorable judgment, order, decree, stipulation or injunction would (i) prevent
consummation of any of the transactions contemplated by this Agreement or (ii)
cause any of the transactions contemplated by this Agreement to be rescinded
following consummation;

         (g) the Company shall have delivered to the Buyer and the Transitory
Subsidiary a certificate (the "Company Certificate") to the effect that each of
the conditions specified in clause (a) of Section 5.1 and clauses (a) through
(e) (insofar as clause (e) relates to Legal Proceedings involving the Company)
of this Section 5.2 is satisfied in all respects;

         (h) The individuals listed on Section 5.2(g) of the Disclosure Schedule
shall have executed and delivered to the Buyer an Employment Agreement in the
form attached hereto as Exhibit C, and all of such agreements shall be in full
force and effect;

         (i) the Buyer shall have received from counsel to the Company an
opinion with respect to the matters set forth in Exhibit D attached hereto,
addressed to the Buyer and dated as of the Closing Date;

         (j) The Escrow Agreement shall have been executed and delivered by each
of the parties thereto;

         (k) the Buyer shall have received copies of the resignations, effective
as of the Effective Time, of each director of the Company (other than any such
resignations which the Buyer designates, by written notice to the Company, as
unnecessary); and

         (l) the Buyer shall have received such certificates of good standing of
the Company in its jurisdiction of organization and the various foreign
jurisdictions in which it is qualified, certified charter documents and
certificates as to the incumbency of officers and the adoption of authorizing
resolutions, as it shall reasonably request in connection with the Closing.

     5.3 Conditions to Obligations of the Company. The obligation of the Company
to consummate the Merger is subject to the satisfaction of the following
additional conditions:

         (a) the Merger Shares shall have been authorized for listing on the
Nasdaq National Market upon official notice of issuance;

                                      -31-
<PAGE>

         (b) the Buyer shall have effected all of the registrations, filings and
notices referred to in Section 4.2 which are required on the part of the Buyer;

         (c) The representations and warranties of the Buyer and the Transitory
Subsidiary contained in this Agreement shall have been true and correct as of
the date of this Agreement and as of the Effective Time except (i) to the extent
that the failure of such representations and warranties to be true and correct
in each case or in the aggregate does not constitute a Buyer Material Adverse
Effect, (ii) for changes contemplated by this Agreement and (iii) for those
representations and warranties which address matters only as of the date of this
Agreement or any other particular date (which shall have been true and correct
as of such particular date except to the extent that the failure of such
representations and warranties to have been true and correct as of such
particular date does not constitute a Buyer Material Adverse Effect) (it being
understood that, for purposes of determining the accuracy of such
representations and warranties all "Material Adverse Effect" qualifications and
other qualifications based on the word "material" or similar phrases contained
in such representations and warranties shall be disregarded);

         (d) each of the Buyer and the Transitory Subsidiary shall have
performed or complied with its agreements and covenants required to be performed
or complied with under this Agreement as of or prior to the Effective Time;

         (e) no Legal Proceeding shall be pending or threatened wherein an
unfavorable judgment, order, decree, stipulation or injunction would have a
Buyer Material Adverse Effect, and no such judgment, order, decree, stipulation
or injunction shall be in effect;

         (f) the Buyer shall have delivered to the Company a certificate (the
"Buyer Certificate") to the effect that each of the conditions specified in
clauses (a) through (e) of this Section 5.3 is satisfied in all respects;

         (g) the Company shall have received from counsel to the Buyer and the
Transitory Subsidiary an opinion with respect to the matters set forth in
Exhibit E attached hereto, addressed to the Company and dated as of the Closing
Date; and

         (h) the Company shall have received such certificates of good standing
of the Buyer and the Transitory Subsidiary in their jurisdiction of
organization, certified charter documents and certificates as to the incumbency
of officers and the adoption of authorizing resolutions, as it shall reasonably
request in connection with the Closing.

                                  ARTICLE VI.
                                 INDEMNIFICATION

     6.1 Indemnification by the Company Shareholders. Subject to the limitations
in Sections 6.4 and 6.5, the Company Shareholders receiving the Merger Shares
pursuant to Section 1.5 (the "Indemnifying Shareholders") shall jointly and
severally as to claims against the Escrow Shares, and severally and not jointly
as to any other claims, indemnify the Buyer in respect of, and hold it harmless
against, any and all debts, obligations and other liabilities (whether absolute,
accrued, contingent, fixed or otherwise, or whether known or unknown, or

                                      -32-
<PAGE>

due or to become due or otherwise), monetary damages, fines, fees, penalties,
interest obligations, deficiencies, losses and expenses (including without
limitation amounts paid in settlement, interest, court costs, reasonable costs
of investigators, reasonable fees and expenses of attorneys, accountants,
financial advisors and other experts, and other reasonable expenses of
litigation) ("Damages") incurred or suffered by the Surviving Corporation or the
Buyer or any Affiliate thereof resulting from or constituting:

         (a) any misrepresentation, breach of warranty or failure to perform any
covenant or agreement of the Company contained in this Agreement or the Company
Certificate; or

         (b) any Third Party Expenses incurred by the Company in excess of
$2,000,000.

     6.2 Indemnification by the Buyer. The Buyer shall indemnify the
Indemnifying Shareholders in respect of, and hold them harmless against, any and
all Damages incurred or suffered by the Indemnifying Shareholders resulting
from, relating to or constituting any misrepresentation, breach of warranty or
failure to perform any covenant or agreement of the Buyer or the Transitory
Subsidiary contained in this Agreement or the Buyer Certificate.

     6.3 Indemnification Claims.

         (a) A party entitled, or seeking to assert rights, to indemnification
under this Article VI (an "Indemnified Party") shall give written notification
to the party from whom indemnification is sought (an "Indemnifying Party") of
the commencement of any suit or proceeding relating to a third party claim for
which indemnification pursuant to this Article VI may be sought. Such
notification shall be given within 20 business days after receipt by the
Indemnified Party of notice of such suit or proceeding, and shall describe in
reasonable detail (to the extent known by the Indemnified Party) the facts
constituting the basis for such suit or proceeding and the amount of the claimed
damages; provided, however, that no delay on the part of the Indemnified Party
in notifying the Indemnifying Party shall relieve the Indemnifying Party of any
liability or obligation hereunder except to the extent of any damage or
liability caused by or arising out of such failure. Within 20 days after
delivery of such notification, the Indemnifying Party may, upon written notice
thereof to the Indemnified Party, assume control of the defense of such suit or
proceeding with counsel reasonably satisfactory to the Indemnified Party;
provided that the Indemnifying Party may not assume control of the defense of a
suit or proceeding involving criminal liability or in which equitable relief is
sought against the Indemnified Party. If the Indemnifying Party does not so
assume control of such defense, the Indemnified Party shall control such
defense. The party not controlling such defense (the "Non-controlling Party")
may participate therein at its own expense; provided that if the Indemnifying
Party assumes control of such defense and the Indemnified Party reasonably
concludes that the Indemnifying Party and the Indemnified Party have conflicting
interests or different defenses available with respect to such suit or
proceeding, the reasonable fees and expenses of counsel to the Indemnified Party
shall be considered "Damages" for purposes of this Agreement. The party
controlling such defense (the "Controlling Party") shall keep the Non-
controlling Party advised of the status of such suit or proceeding and the
defense thereof and shall consider in good faith

                                      -33-
<PAGE>

recommendations made by the Non-controlling Party with respect thereto. The
Non-controlling Party shall furnish the Controlling Party with such information
as it may have with respect to such suit or proceeding (including copies of any
summons, complaint or other pleading which may have been served on such party
and any written claim, demand, invoice, billing or other document evidencing or
asserting the same) and shall otherwise cooperate with and assist the
Controlling Party in the defense of such suit or proceeding. The Indemnifying
Party shall not agree to any settlement of, or the entry of any judgment arising
from, any such suit or proceeding without the prior written consent of the
Indemnified Party, which shall not be unreasonably withheld or delayed. The
Indemnified Party shall not agree to any settlement of, or the entry of any
judgment arising from, any such suit or proceeding without the prior written
consent of the Indemnifying Party, which shall not be unreasonably withheld or
delayed.

         (b) In order to seek indemnification under this Article VI, an
Indemnified Party shall give written notification (a "Claim Notice") to the
Indemnifying Party which contains (i) a description and the amount (the "Claimed
Amount") of any Damages incurred or reasonably expected to be incurred by the
Indemnified Party, (ii) a statement that the Indemnified Party is entitled to
indemnification under this Article VI for such Damages and a reasonable
explanation of the basis therefor, and (iii) a demand for payment (in the manner
provided in paragraph (c) below) in the amount of such Damages. If the
Indemnified Party is the Buyer, the Indemnifying Party shall deliver a copy of
the Claim Notice to the Escrow Agent. The Claim Notice shall be delivered by the
Indemnified Party as soon as practicable after the Indemnified Party has
knowledge of the related Damages, provided however, that no delay on the part of
the Indemnified Party in delivering such Claim Notice shall relieve the
Indemnifying Party of any liability or obligation hereunder except to the extent
of any damage or liability caused by or arising out of such failure.

         (c) Within 20 days after delivery of a Claim Notice in the form
required by Section 6.3(b), the Indemnifying Party shall deliver to the
Indemnified Party a written response (the "Response") in which the Indemnifying
Party shall: (i) agree that the Indemnified Party is entitled to receive all of
the Claimed Amount (in which case the Response shall be accompanied by a payment
by the Indemnifying Party to the Indemnified Party of the Claimed Amount, by
check or by wire transfer; provided that if the Indemnified Party is the Buyer,
then such payment shall not be made by check or wire transfer, and instead the
Indemnifying Party and the Indemnified Party shall deliver to the Escrow Agent,
within three days following the delivery of the Response, a written notice
executed by both parties instructing the Escrow Agent to distribute to the Buyer
such number of Escrow Shares as have an aggregate Value (as defined below) equal
to the Claimed Amount), (ii) agree that the Indemnified Party is entitled to
receive part, but not all, of the Claimed Amount (the "Agreed Amount") (in which
case the Response shall be accompanied by a payment by the Indemnifying Party to
the Indemnified Party of the Agreed Amount, by check or by wire transfer;
provided that if the Indemnified Party is the Buyer, then such payment shall not
be made by check or wire transfer, and instead the Indemnifying Party and the
Indemnified Party shall deliver to the Escrow Agent, within three days following
the delivery of the Response, a written notice executed by both parties
instructing the Escrow Agent to distribute to the Buyer such number of Escrow
Shares as have an aggregate Value equal to the Agreed Amount) or (iii) dispute
that the Indemnified Party is entitled to receive any of the Claimed Amount. If
the Indemnifying Party in the Response disputes its

                                      -34-
<PAGE>

liability for all or part of the Claimed Amount, the Indemnifying Party and the
Indemnified Party shall follow the procedures set forth in Section 6.3(d) for
the resolution of such dispute (a "Dispute"). For purposes of this Article VI,
the "Value" of any Escrow Shares delivered in satisfaction of an indemnity claim
shall be the average closing price for 5 trading days preceding the date of this
Agreement (subject to equitable adjustment in the event of any stock split,
stock dividend, reverse stock split or similar event affecting the Buyer Common
Stock since the date hereof), multiplied by the number of such Escrow Shares.

         (d) During the 60-day period following the delivery of a Response that
reflects a Dispute, the Indemnifying Party and the Indemnified Party shall use
good faith efforts to resolve the Dispute. If the Dispute is not resolved within
such 60-day period, the Indemnifying Party and the Indemnified Party shall
discuss in good faith the submission of the Dispute to a mutually acceptable
alternative dispute resolution procedure (which may be non-binding or binding
upon the parties, as they agree in advance) (the "ADR Procedure"). In the event
the Indemnifying Party and the Indemnified Party agree upon an ADR Procedure,
such parties shall, in consultation with the chosen dispute resolution service
(the "ADR Service"), promptly agree upon a format and timetable for the ADR
Procedure, agree upon the rules applicable to the ADR Procedure, and promptly
undertake the ADR Procedure. The provisions of this Section 6.3(d) shall not
obligate the Indemnifying Party and the Indemnified Party to pursue an ADR
Procedure or prevent either such party from pursuing the Dispute in a court of
competent jurisdiction; provided that, if the Indemnifying Party and the
Indemnified Party agree to pursue an ADR Procedure, neither the Indemnifying
Party nor the Indemnified Party may commence litigation or seek other remedies
with respect to the Dispute prior to the completion of such ADR Procedure. Any
ADR Procedure undertaken by the Indemnifying Party and the Indemnified Party
shall be considered a compromise negotiation for purposes of federal and state
rules of evidence, and all statements, offers, opinions and disclosures (whether
written or oral) made in the course of the ADR Procedure by or on behalf of the
Indemnifying Party, the Indemnified Party or the ADR Service shall be treated as
confidential and, where appropriate, as privileged work product. Such
statements, offers, opinions and disclosures shall not be discoverable or
admissible for any purposes in any litigation or other proceeding relating to
the Dispute (provided that this sentence shall not be construed to exclude from
discovery or admission any matter that is otherwise discoverable or admissible).
The fees and expenses of any ADR Service used by the Indemnifying Party and the
Indemnified Party shall be shared equally by the Indemnifying Party and the
Indemnified Party. If the Indemnified Party is the Buyer, the Indemnifying Party
and the Indemnified Party shall deliver to the Escrow Agent, promptly following
the resolution of the Dispute (whether by mutual agreement, pursuant to an ADR
Procedure, as a result of a judicial decision or otherwise), a written notice
executed by both parties instructing the Escrow Agent as to what (if any)
portion of the Escrow Shares shall be distributed to the Buyer and/or the
Indemnifying Shareholders (which notice shall be consistent with the terms of
the resolution of the Dispute).

         (e) Notwithstanding the other provisions of this Section 6.3, if a
third party asserts (other than by means of a lawsuit) that an Indemnified Party
is liable to such third party for a monetary or other obligation which may
constitute or result in Damages for which such Indemnified Party may be entitled
to indemnification pursuant to this Article VI, and such Indemnified Party
reasonably determines that it has a valid business reason to fulfill such

                                      -35-
<PAGE>

obligation, then (i) such Indemnified Party shall be entitled to satisfy such
obligation, without prior notice to or consent from the Indemnifying Party, (ii)
such Indemnified Party may subsequently make a claim for indemnification in
accordance with the provisions of this Article VI, and (iii) such Indemnified
Party shall be reimbursed, in accordance with the provisions of this Article VI,
for any such Damages for which it is entitled to indemnification pursuant to
this Article VI (subject to the right of the Indemnifying Party to dispute the
Indemnified Party's entitlement to indemnification, or the amount for which it
is entitled to indemnification (including without limitation to the extent
prejudiced by the actions taken by the Indemnified Party hereunder), under the
terms of this Article VI).

         (f) For purposes of this Section 6.3 and the last two sentences of
Section 6.4, (i) if the Indemnifying Shareholders comprise the Indemnifying
Party, any references to the Indemnifying Party (except provisions relating to
an obligation to make or a right to receive any payments provided for in Section
6.3 or Section 6.4) shall be deemed to refer to the Indemnification
Representatives, and (ii) if the Indemnifying Shareholders comprise the
Indemnified Party, any references to the Indemnified Party (except provisions
relating to an obligation to make or a right to receive any payments provided
for in Section 6.3 or Section 6.4) shall be deemed to refer to the
Indemnification Representatives. The Indemnification Representatives shall have
full power and authority on behalf of each Indemnifying Shareholder to take any
and all actions on behalf of, execute any and all instruments on behalf of, and
execute or waive any and all rights of, the Indemnifying Shareholders under this
Article VI. The Indemnification Representatives shall have no liability to any
Indemnifying Shareholder for any action taken or omitted on behalf of the
Indemnifying Shareholders pursuant to this Article VI.

     6.4 Survival of Representations and Warranties. All representations and
warranties contained in this Agreement, the Company Certificate or the Buyer
Certificate shall (a) survive the Closing and any investigation at any time made
by or on behalf of an Indemnified Party and (b) shall expire on the date one
year following the Closing Date. If an Indemnified Party delivers to an
Indemnifying Party, before expiration of a representation or warranty, either a
Claim Notice based upon a breach of such representation or warranty, or a notice
that, as a result a legal proceeding instituted by or written claim made by a
third party, the Indemnified Party reasonably expects to incur Damages as a
result of a breach of such representation or warranty (an "Expected Claim
Notice"), then such representation or warranty shall survive until, but only for
purposes of, the resolution of the matter covered by such notice. If the legal
proceeding or written claim with respect to which an Expected Claim Notice has
been given is definitively withdrawn or resolved in favor of the Indemnified
Party, the Indemnified Party shall promptly so notify the Indemnifying Party;
and if the Indemnified Party has delivered a copy of the Expected Claim Notice
to the Escrow Agent and Escrow Shares have been retained in escrow after the
Termination Date (as defined in the Escrow Agreement) with respect to such
Expected Claim Notice, the Indemnifying Party and the Indemnified Party shall
promptly deliver to the Escrow Agent a written notice executed by both parties
instructing the Escrow Agent to distribute such retained Escrow Shares to the
Indemnifying Shareholders in accordance with the terms of the Escrow Agreement.

                                      -36-
<PAGE>

     6.5 Limitations.

         (a) Notwithstanding anything to the contrary herein, the aggregate
liability of the Indemnifying Shareholders, on the one hand, and the Buyer, on
the other hand, for Damages under this Article VI shall not exceed the value of
the Escrow Shares, except that such limitation shall not apply to limit the
liability of any Indemnifying Shareholder or the Buyer for fraud by such
Indemnifying Shareholder or the Buyer, as the case may be. For purposes solely
of this Article VI, all representations and warranties of the Company in Article
II (other than Sections 2.6, 2.7, 2.13(a), 2.14(a), 2.20(a), 2.29 and 2.30) and
all representations and warranties of the Buyer and the Transitory Subsidiary
(other than Sections 3.5 (as to the penultimate sentence only), 3.8, 3.9 and
3.10) shall be construed as if the term "material" and any reference to "Company
Material Adverse Effect" and "Buyer Material Adverse Effect" (and variations
thereof) were omitted from such representations and warranties, except to the
extent such references qualify the requirements of the Buyer to list specified
agreements, documents or permits on the Disclosure Schedule.

         (b) Neither the Indemnifying Shareholders on the one hand, nor the
Buyer on the other, shall be liable for Damages incurred by the other under this
Article VI unless and until such Damages, together with all other Damages
incurred by such other party, exceed $250,000, in which case such Indemnifying
Party shall only be liable for such Damages in excess of $250,000; provided,
that the foregoing limitation shall not apply with respect to claims made by the
Buyer pursuant to Section 6.1(b).

         (c) After the Closing, the rights of the Indemnified Parties under this
Article VI and the Escrow Agreement shall be the exclusive remedy of the
Indemnified Parties with respect to claims resulting from or relating to any
misrepresentation, breach of warranty or failure to perform any covenant or
agreement contained in this Agreement, except that such limitation shall not
apply to limit the liability of any Indemnifying Shareholder or the Buyer for
fraud by such Indemnifying Shareholder or the Buyer, as the case may be.

         (d) No Indemnifying Shareholder shall have any right of contribution
against the Company or the Surviving Corporation with respect to any breach by
the Company of any of its representations, warranties, covenants or agreements.

                                   ARTICLE VII.
                                   TERMINATION

         7.1 Termination of Agreement. The Parties may terminate this Agreement
prior to the Effective Time (whether before or after Requisite Shareholder
Approval), as provided below:

         (a) the Parties may terminate this Agreement by mutual written consent;

         (b) the Buyer may terminate this Agreement by giving written notice to
the Company in the event the Company is in breach of any representation,
warranty or covenant contained in this Agreement, and such breach, individually
or in combination with any other such breach, (i) would cause the conditions set
forth in clauses (c) or (d) of Section 5.2 not to be

                                      -37-
<PAGE>

satisfied and (ii) is not cured within 20 days following delivery by the Buyer
to the Company of written notice of such breach;

         (c) the Company may terminate this Agreement by giving written notice
to the Buyer in the event the Buyer or the Transitory Subsidiary is in breach of
any representation, warranty or covenant contained in this Agreement, and such
breach, individually or in combination with any other such breach, (i) would
cause the conditions set forth in clauses (c) or (d) of Section 5.3 not to be
satisfied and (ii) is not cured within 20 days following delivery by the Company
to the Buyer of written notice of such breach;

         (d) any Party may terminate this Agreement by giving written notice to
the other Parties at any time after the Company Shareholders have voted on
whether to approve this Agreement and the Merger in the event this Agreement and
the Merger failed to receive the Requisite Shareholder Approval;

         (e) the Buyer may terminate this Agreement by giving written notice to
the Company if the Closing shall not have occurred on or before April 30, 2000
by reason of the failure of any condition precedent under Section 5.1 or 5.2
hereof (unless the failure results primarily from a breach by the Buyer or the
Transitory Subsidiary of any representation, warranty or covenant contained in
this Agreement); or

         (f) the Company may terminate this Agreement by giving written notice
to the Buyer and the Transitory Subsidiary if the Closing shall not have
occurred on or before April 30, 2000 by reason of the failure of any condition
precedent under Section 5.1 or 5.3 hereof (unless the failure results primarily
from a breach by the Company of any representation, warranty or covenant
contained in this Agreement).

     7.2 Effect of Termination. If any Party terminates this Agreement pursuant
to Section 7.1, all obligations of the Parties hereunder shall terminate without
any liability of any Party to any other Party (except for any liability of any
Party for willful breaches of this Agreement).

                                  ARTICLE VIII.
                               REGISTRATION RIGHTS

     8.1 Certain Definitions. As used in this Article VIII, the following terms
shall have the following respective meanings:

         (a) "Resale Holder" means: (i) a Company Shareholder to whom shares of
Buyer Common Stock are issued pursuant to this Agreement and the Merger, or (ii)
the Escrow Agent (as defined in the Escrow Agreement), or (iii) a transferee to
whom registration rights granted under this Article VIII are assigned pursuant
to Section 8.7 hereof.

         (b) "Registrable Securities" means for any Resale Holder the number of
shares of Buyer Common Stock issued to such Resale Holder pursuant to this
Agreement and the Merger, and for all Resale Holders the sum of the Registrable
Securities held by them; provided, however, that such shares of Buyer Common
Stock held by a particular Resale Holder shall

                                      -38-
<PAGE>

cease to be Registrable Securities on the earlier of (i) first anniversary of
the Effective Time or (ii) such time as such Resale Holder is able to sell such
shares (including all Registrable Securities held by Affiliates of such Resale
Holder) in their entirety within a single 90 day period under Rule 144 of the
Securities Act.

     8.2 Resale Holder Registration.

         (a) The Buyer shall use its best efforts to cause the Registrable
Securities then held by each Resale Holder to be registered under the Securities
Act so as to permit the sale thereof as set forth in this Section 8.2. The Buyer
shall prepare and file with the SEC (i) if a registration statement for an
Underwritten Sale (as defined in Section 8.3(a) below) has been filed on or
before March 15, 2000, on or before April 15, 2000 or (ii) otherwise, on or
before March 31, 2000, a registration statement in such form as is then
available under the Securities Act covering the Registrable Securities of all
Resale Holders not previously sold pursuant to Section 8.3 hereof (the "Shelf
Registration Statement"); provided, however, that the obligation of Buyer to use
its reasonable best efforts to cause the registration of the Registrable
Securities to be sold pursuant to the Shelf Registration Statement shall not
include any obligation of the Buyer to request acceleration of such Shelf
Registration Statement prior to May 15, 2000; and provided, further that each
Resale Holder shall provide all such information and materials and take all such
action as may be required in order to permit the Buyer to comply with all
applicable requirements of the Securities Act and the Exchange Act and to obtain
any desired acceleration of the effective date of such Shelf Registration
Statement, such provision of information and materials to be a condition
precedent to the obligations of the Buyer pursuant to this Article VIII to
register the Registrable Securities held by such Resale Holder. The offerings
made pursuant to the Shelf Registration Statement shall not be underwritten and
the Company and each Resale Holder acknowledges that other holders of Buyer
Common Stock may exercise rights to have the Shelf Registration Statement cover
their resale of shares of Buyer Common Stock.

         (b) The Buyer shall (i) prepare and file with the Commission the Shelf
Registration Statement in accordance with Section 8.2 hereof with respect to the
Registrable Securities and shall use its best efforts to cause such registration
statements to become effective by May 15, 2000 and to keep such registration
statement effective until the sooner to occur of (A) the date on which all
Registrable Securities included within such registration statements have been
sold or (B) the first date following the Effective Time as to which no
Registrable Securities exist as a result of the proviso to Section 8.1(b); (ii)
prepare and file with the Commission such amendments to such registration
statements and amendments or supplements to the prospectuses used in connection
therewith as may be necessary to comply with the provisions of the Securities
Act with respect to the sale or other disposition of all securities registered
by such registration statement (including such amendments as may be necessary to
reflect different or additional selling stockholders as a result of any
distribution of Registrable Securities by the Resale Holders to the beneficial
owners of such Registrable Securities); (iii) furnish to each Resale Holder such
number of copies of any prospectus (including any preliminary prospectus and any
amended, combined or supplemented prospectus) in conformity with the
requirements of the Securities Act, and such other documents, as each Resale
Holder may reasonably request in order to effect the offering and sale of the
Registrable Securities to be offered and sold, but only while the Buyer shall be
required under the provisions hereof to cause the

                                      -39-
<PAGE>

registration statements to remain effective; (iv) use its reasonable best
efforts to register or qualify the Registrable Securities covered by such
registration statements under the securities or blue sky laws of such
jurisdictions as each Resale Holder shall reasonably request (provided that the
Buyer shall not be required in connection therewith or as a condition thereto to
qualify to do business or to file a general consent to service of process in any
such jurisdiction where it has not been qualified), and do any and all other
acts or things which may be necessary or advisable to enable each Resale Holder
to consummate the public sale or other disposition of such Registrable
Securities in such jurisdictions; (v) notify each Resale Holder, promptly after
it shall receive notice thereof, of the date and time the registration
statements and each post-effective amendment to such registration statements
become effective or a supplement to any prospectus forming a part of such
registration statements has been filed; and (vi) promptly reissue, or promptly
authorize and instruct its transfer agent to reissue, unlegended certificates at
the request of any Resale Holder thereof upon such Resale Holder's delivery of
original certificates representing Registrable Securities tendered for sale
pursuant to such effective registration statements, and to promptly respond to
broker's inquiries made of the Buyer in connection with such sales, in each case
with a view to reasonably assisting the Resale Holder to complete such sale
during such period of effectiveness.

         (c) If the Shelf Registration Statement shall not have been declared
effective on or before May 15, 2000 as a result of the Buyer's failure to use
best efforts consistent with the provisions of Section 8.2 (b) (but a good faith
dispute by the Buyer of disclosure requested by the SEC for a period not
exceeding 45 days from the date such SEC request has been received from the SEC
shall not be deemed a failure to use best efforts by the Buyer), then the Buyer
shall make a Make up Payment (as defined below) to the former Company
Shareholders. If the Shelf Registration Statement shall not have been declared
effective on or before June 30, 2000 for any reason other than the Buyer's
failure to use best efforts consistent with the provisions of Section 8.2(b)
(but a good faith dispute by the Buyer of disclosure requested by the SEC for a
period not exceeding 45 days from the date such SEC request has been received
from the SEC shall not be deemed a failure to use best efforts by the Buyer),
then the Buyer shall make a Make Up Payment to the former Company Shareholders.
For purposes of this Section 8.2(c), a "Make Up Payment" shall equal the lesser
of (i) the product of (x) 366,250 (732,500 following the effect of the Buyer
Stock Split) and (y) the Buyer Common Stock Differential (as defined below), and
(ii) $10,000,000. For purposes of the first sentence of this Section 8.2(c), the
"Buyer Common Stock Differential" shall equal the difference, if any, between
(x) the average closing sale price of the Buyer Common Stock as reported on the
Nasdaq National Market for the ten consecutive trading days prior to May 15,
2000 and (y) the average closing sale price of the Buyer Common Stock as
reported on the Nasdaq National Market for the ten consecutive trading days
prior to the effective date of the Shelf Registration Statement (or June 1, 2000
if the Shelf Registration Statement shall not be declared effective on or before
June 1, 2000). For purposes of the second sentence of this Section 8.2(c), the
"Buyer Common Stock Differential" shall equal the difference, if any between (x)
the average closing sale price of the Buyer Common Stock as reported on the
Nasdaq National Market for all trading days from May 15, 2000 to June 30, 2000
(inclusive) and (y) the average closing sale price of the Buyer Common Stock as
reported on the Nasdaq National Market for all trading days from July 1, 2000 to
the effective date of the Shelf Registration Statement (inclusive) (or July 31,
2000 if the Shelf Registration Statement shall not be declared effective on or
before July 31, 2000). The Buyer shall pay the Make Up Payment

                                      -40-
<PAGE>

within 10 days of it becoming due and calculable, pro rata to the former Company
Shareholders based upon the ownership of Buyer Common Stock received in the
Merger pursuant to Section 1.5 and may elect to pay any Make Up Payment in cash
or in shares of Buyer Common Stock (valued for these purposes at the average
price determined pursuant to clause (y) of the applicable definition of Buyer
Common Stock Differential above).

         (d) Notwithstanding the foregoing obligations of the Buyer under this
Section 8.2, if (i) the Resale Holders are given the opportunity to include in
the aggregate at least 366,250 (732,500 following the effect of the Buyer Stock
Split) Registrable Securities and (ii) any Resale Holder that exercises its
rights under Section 8.3 below is permitted to include at least 33% of its
Registrable Securities, in an Underwritten Sale pursuant to a registration
statement that is declared effective on or before April 30, 2000, then the Buyer
may determine the date to file the Shelf Registration Statement pursuant to
Section 8.1(a) in its sole discretion and the Buyer shall not be required to use
its best efforts to have the Shelf Registration Statement Effective by May 15,
2000, but instead the Buyer shall be obligated to have the Shelf Registration
Statement declared effective on or before the date on which the contractual
prohibitions on the sale of Buyer Common Stock imposed by the underwriters of
the Underwritten Sale on holders of Buyer Common Stock selling shares in such
Underwritten Sale, officers and directors of the Buyer or certain holders of 5%
or more of the outstanding shares of Buyer Common Stock terminate.

     8.3 Company Registration.

         (a) The Buyer may determine to provide for the firmly underwritten sale
of Buyer Common Stock for its own account and/or the account of other
stockholders, and in connection with such determination, file with the SEC a
registration statement to register such Buyer Common Stock (an "Underwritten
Sale"). The Buyer shall give prompt written notice to the Resale Holders of the
filing of a registration statement relating to any Underwritten Sale where such
filing is made on or before April 15, 2000 and any Resale Holder may participate
in such Underwritten Sale (and any related qualification under blue sky laws or
other related compliance) by providing written notice to the Buyer within 10
calendar days of the delivery of the foregoing notice from the Buyer. If in the
good faith judgment of the managing underwriter of the Underwritten Sale, the
inclusion of all or any portion of the Registrable Shares requested to be
included in the Underwritten Sale would reduce the number of shares to be
offered by the Buyer or interfere with the successful marketing of the
securities offered by the Buyer, the number of Registrable Shares otherwise to
be included by Resale Holders in the Underwritten Sale may be reduced pro rata
or excluded altogether; provided, that the Registrable Shares must be treated in
the same manner as shares of Buyer Common Stock held all other selling security
holders. To facilitate the allocation of shares in accordance with the above
provision, the Buyer or the underwriters may round the number of shares
allocated to any Resale Holder to the nearest 100 shares.

         (b) All Resale Holders distributing Registrable Securities through the
Underwritten Sale shall (together with the Buyer and the other holders
distributing their securities through the Underwritten Sale) enter into an
underwriting agreement in customary form with the managing underwriter. The
underwriter(s) for an Underwritten Sale shall be

                                      -41-
<PAGE>

selected by the Buyer in its sole discretion. If any Resale Holder disapproves
of the terms of the Underwritten Sale, he or she may elect to withdraw therefrom
by written notice to the Buyer and the managing underwriter.

     8.4 Suspension of Prospectus. The Buyer may restrict disposition of
Registrable Securities pursuant to the Shelf Registration Statement, and a
Resale Holder will not be able to dispose of such Registrable Securities
pursuant to the Shelf Registration Statement, if the Buyer shall have delivered
a notice in writing to such Resale Holder stating that a delay in the
disposition of such Registrable Securities is necessary because the Buyer, in
its reasonable judgment, has determined in good faith that such sales would
require public disclosure by the Buyer of material nonpublic information that is
not included in such registration statement and that immediate disclosure of
such information would be seriously detrimental to the Buyer. In the event of
the delivery of the notice described above by the Buyer, the Buyer shall use its
reasonable best efforts to amend such registration statement and/or amend or
supplement the related prospectus if necessary and to take all other actions
necessary to allow the proposed sale to take place as promptly as possible,
subject, however, to the right of the Buyer to delay further sales of
Registrable Securities until the conditions or circumstances referred to in the
notice have ceased to exist or have been disclosed. Such right to delay sales of
Registrable Securities shall not exceed 90 days in the aggregate and no longer
than 30 days as to any single delay (any such period of delay herein referred to
as a "blackout period"); after the Shelf Registration Statement is declared
effective, no blackout period may be imposed during the 15-day period following
the date of effectiveness or the termination date of the last blackout period.
In addition, each Resale Holder who becomes an employee of the Buyer shall be
subject to the trading restrictions related to the release of quarterly results
of operations in the same manner as other similar employees of the Buyer.

     8.5 Expenses. All of the out-of-pocket expenses incurred in connection with
any registration of Registrable Securities pursuant to this Article VIII,
including, without limitation, all SEC, Nasdaq National Market and blue sky
registration and filing fees, printing expenses, transfer agents' and
registrars' fees, and the reasonable fees and disbursements of the Buyer's
outside counsel and independent accountants shall be paid by the Buyer. The
Buyer shall not be responsible to pay any legal fees for any Resale Holder or
any selling expenses of any Resale Holder (including, without limitation, any
broker's fees or commissions, including underwriter commissions).

     8.6 Indemnification. In the event of any offering registered pursuant to
this Article VIII:

         (a) The Buyer will indemnify each Resale Holder, each of its officers,
directors and partners and such Resale Holder's legal counsel and independent
accountants, and each person controlling such Resale Holder within the meaning
of Section 15 of the Securities Act, with respect to which registration,
qualification or compliance has been effected pursuant to this Article VIII, and
each underwriter, if any, and each person who controls any underwriter within
the meaning of Section 15 of the Securities Act, against all expenses, claims,
losses, damages and liabilities (or actions in respect thereof), including any
of the foregoing incurred in settlement of any litigation, commenced or
threatened, arising out of or based on any untrue

                                      -42-
<PAGE>

statement (or alleged untrue statement) of a material fact contained in any
registration statement, prospectus, offering circular or other document, or any
amendment or supplement thereto, incident to any such registration,
qualification or compliance, or based on any omission (or alleged omission) to
state therein a material fact required to be stated therein or necessary to make
the statements therein, in light of the circumstances in which they are made,
not misleading, or any violation by the Buyer of any rule or regulation
promulgated under the Securities Act, or state securities laws, or common law,
applicable to the Buyer in connection with any such registration, qualification
or compliance, and will reimburse (and advance the same to) each such Resale
Holder, each of its officers, directors and partners and such Resale Holder's
legal counsel and independent accountants, and each person controlling such
Resale Holder, each such underwriter and each person who controls any such
underwriter, for any legal and any other expenses reasonably incurred in
connection with investigating, preparing or defending any such claim, loss,
damage, liability or action, provided that the Buyer will not be liable in any
such case to the extent that any such claim, loss, damage, liability or expense
arises out of or is based in any untrue statement or omission or alleged untrue
statement or omission, made in reliance upon and in conformity with written
information furnished to the Buyer in an instrument duly executed by such Resale
Holder or underwriter and stated to be specifically for use therein; provided,
however, that in the case of the Shelf Registration Statement the foregoing is
subject to the condition that, insofar as it relates to any such untrue
statement, alleged untrue statement, omission or alleged omission made in a
preliminary prospectus on file with the Commission at the time the registration
statement becomes effective or the amended prospectus is filed with the
Commission pursuant to Rule 424(b) (the "Final Prospectus"), the provisions
hereof shall not inure to the benefit of any Resale Holder, if the Buyer had
complied with its obligations under Section 8.2(b)(iii) with respect to such
Final Prospectus and a copy of the Final Prospectus was not furnished to the
person asserting the loss, liability, claim or damage at or prior to the time
such action is required by the Securities Act, and if the Final Prospectus would
have cured the defect giving rise to the loss, liability, claim or damage.

         (b) Each Resale Holder will, if Registrable Securities held by such
Resale Holder are included in the securities as to which such registration,
qualification or compliance is being effected, indemnify the Buyer, each of its
directors and officers and its legal counsel and independent accountants, each
underwriter, if any, of the Buyer's securities covered by such a registration
statement, each person who controls the Buyer or such underwriter within the
meaning of Section 15 of the Securities Act, and each other such Resale Holder,
each of its officers and directors and each person controlling such Resale
Holder within the meaning of Section 15 of the Securities Act, against all
claims, losses, damages and liabilities (or actions in respect thereof) arising
out of or based on any untrue statement (or alleged untrue statement) of a
material fact contained in any such registration statement, prospectus, offering
circular or other document, or any omission (or alleged omission) to state
therein a material fact required to be stated therein or necessary to make the
statements therein not misleading, and will reimburse the Buyer, such Resale
Holders, such directors, officers, legal counsel, independent accountants,
underwriters or control persons for any legal or any other expenses reasonably
incurred in connection with investigating or defending any such claim, loss,
damage, liability or action, in each case to the extent, but only to the extent,
that such untrue statement (or alleged untrue statement) or omission (or alleged
omission) is made in such registration statement, prospectus, offering circular
or other document in reliance upon and in conformity with written information

                                      -43-
<PAGE>

furnished to the Buyer by an instrument duly executed by such Resale Holder and
stated to be specifically for use therein; provided, however, that the
obligations of such Resale Holders hereunder shall be limited to an amount equal
to the net proceeds received by each such Resale Holder of Registrable
Securities actually sold as contemplated herein.

         (c) Each party entitled to indemnification under this Section 8.6 (the
"Securities Indemnified Party") shall give notice to the party required to
provide indemnification (the "Securities Indemnifying Party") promptly after
such Securities Indemnified Party has written notice of any claim as to which
indemnity may be sought, and shall permit the Securities Indemnifying Party to
assume the defense of any such claim or any litigation resulting therefrom,
provided that counsel for the Securities Indemnifying Party, who shall conduct
the defense of such claim or litigation, shall be approved by the Securities
Indemnified Party (whose approval shall not be unreasonably withheld), and the
Securities Indemnified Party may participate in such defense at such party's
expense, and provided further that the failure of any Securities Indemnified
Party to give notice as provided herein shall not relieve the Securities
Indemnifying Party of its obligations under this Article VIII; provided that if
the Securities Indemnified Party has claims against the Securities Indemnifying
Party or otherwise has claims or defenses different from or in addition to those
of the Securities Indemnifying Party, the Securities Indemnified Party may
retain counsel of its own choice for all Resale Holders, and the reasonable fees
and expenses of such counsel shall be paid by the Securities Indemnifying Party.
No Securities Indemnifying Party, in the defense of any such claim or
litigation, shall, except with the consent of each Securities Indemnified Party,
consent to entry of any judgment or enter any settlement which does not include
as an unconditional term thereof the giving by the claimant or plaintiff to the
Securities Indemnified Party of a release from all liability in respect to such
claim or litigation.

         (d) The obligations of the Buyer and each Resale Holder under this
Section 8.6 shall survive the completion of any offering of Registrable
Securities in a registration statement under this Article VIII and otherwise.

         (e) To the extent the provisions of this Section 8.6 are inconsistent
with or conflict with the terms of any underwriting, indemnification, selling or
similar agreement entered into by a Resale Holder in connection with the offer
and sale of Registrable Securities pursuant to a registration effected pursuant
to this Article VIII, the terms of such agreement shall govern and shall
supersede the provisions of this Article VIII.

     8.7 Limitation on Assignment of Registration Rights. The rights to cause
the Buyer to register Registrable Securities pursuant to this Article VIII may
not be assigned by a Resale Holder unless such a transfer is to stockholders,
partners or retired partners, or members or retired members of a Resale Holder
(including spouses and ancestors, lineal descendants, and siblings of such
stockholders, partners, members or spouses who acquire Registrable Securities by
right, will, or intestate succession). Prior to a permitted transfer of
registration rights under this Article VIII, a Resale Holder must furnish the
Buyer with written notice of the name and address of such transferee and the
Registrable Securities with respect to which such registration rights are being
assigned and a copy of a duly executed written instrument in form reasonably
satisfactory to the Buyer by which such transferee assumes all of the
obligations and liabilities of

                                      -44-
<PAGE>

its transferor hereunder and agrees itself to be bound hereby. No transfer of
registration rights under this Article VIII shall be permitted if immediately
following such transfer the disposition of such Registrable Securities by the
transferee is not restricted under the Securities Act; provided that the Buyer
shall have provided such transferee with certificates representing such
Registrable Securities free of any transfer restrictions and the Buyer shall
have instructed the transfer agent for such Registrable Securities to remove any
stop transfer or other instructions.

                                   ARTICLE IX.
                                   DEFINITIONS

     For purposes of this Agreement, each of the following defined terms is
defined in the Section of this Agreement indicated below.

                Defined Term                              Section
                ------------                              -------
                ADR Procedure                             6.3(d)
                ADR Service                               6.3(d)
                Affiliate                                 2.15(a)(viii)
                Affiliate Agreement                       4.9
                Agreed Amount                             6.3(c)
                Buyer                                     Introduction
                Buyer Certificate                         5.3(f)
                Buyer Common Stock                        1.5(a)
                Buyer Common Stock Differential           8.2(c)
                Buyer Material Adverse Effect             3.1
                Buyer Reports                             3.5
                Buyer Stock Split                         1.5(b)
                CERCLA                                    2.22(a)
                Certificates                              1.7
                Certificate of Merger                     1.1
                Claim Notice                              6.3(b)
                Claimed Amount                            6.3(b)
                Closing                                   1.2
                Closing Date                              1.2
                Code                                      1.8(a)
                Common Shares                             1.5(a)
                Company                                   Introduction
                Company Certificate                       5.2(f)
                Company Intellectual Property             2.13(a)
                Company Material Adverse Effect           2.1
                Company Meeting                           2.29
                Company Shares                            1.5(a)
                Company Shareholders                      1.5(b)
                Controlling Party                         6.3(a)
                Conversion Ratio                          1.5(b)
                Customer Deliverables                     2.13(a)

                                      -45-
<PAGE>

                Damages                                   6.1
                Disclosure Schedule                       Article II
                Dispute                                   6.3(c)
                Dissenting Shares                         1.6(a)
                Effective Time                            1.1
                Employee Benefit Plan                     2.21(a)
                Environmental Law                         2.22(a)
                ERISA                                     2.21(a)
                Escrow Agreement                          1.3(f)
                Escrow Agent                              1.3(f)
                Escrow Shares                             1.5(b)
                Expected Claim Notice                     6.4
                Exchange Act                              2.15(a)(viii)
                Exchange Agent                            1.13(a)
                Final Prospectus                          8.6(a)
                Financial Statements                      2.6
                GAAP                                      2.6
                Governmental Entity                       2.4
                Indemnification Representatives           1.3(f)
                Indemnified Party                         6.3(a)
                Indemnifying Party                        6.3(a)
                Indemnifying Shareholders                 6.1
                Initial Shares                            1.5(b)
                Intellectual Property                     2.13(a)
                Internal Systems                          2.13(a)
                Legal Proceeding                          2.18
                Make Up Payment                           8.2(c)
                Material Adverse Effect                   5.2(c)
                Materials of Environmental Concern        2.22(b)
                Merger                                    1.1
                Merger Shares                             1.5(b)
                Most Recent Balance Sheet                 2.8
                Most Recent Balance Sheet Date            2.6
                Non-controlling Party                     6.3(a)
                Option Plan                               1.8(a)
                Options                                   1.8(a)
                Ordinary Course of Business               2.4
                Parties                                   Introduction
                Permits                                   2.25
                Preferred Shares                          1.5(a)
                Proxy Statement                           2.29
                Reasonable Best Efforts                   4.1
                Resale Holder                             8.1(a)
                Registrable Securities                    8.1(b)
                Response                                  6.3(c)

                                      -46-
<PAGE>

                Retention Options                         4.12
                Requisite Shareholder Approval            2.3
                SEC                                       3.5
                Securities Act                            2.2
                Securities Indemnified Party              8.6(c)
                Securities Indemnifying Party             8.6(c)
                Security Interest                         2.4
                Series A Shares                           1.5(a)
                Series B Shares                           1.5(a)
                Shelf Registration Statement              8.2(a)
                Software                                  2.13(e)
                SVB Warrant                               1.8(d)
                Surviving Corporation                     1.1
                Taxes                                     2.9(a)(i)
                Tax Returns                               2.9(a)(ii)
                Third Party Expenses                      4.8
                Transitory Subsidiary                     Introduction
                Underwritten Sale                         8.3(a)
                Value                                     6.3(c)
                Warrants                                  1.8(d)
                Year 2000 Compliant                       2.14(c)

                                    ARTICLE X.
                                  MISCELLANEOUS

     10.1 Press Releases and Announcements. No Party shall issue any press
release or public disclosure relating to the subject matter of this Agreement
without the prior written approval of the other Parties; provided, however, that
the Buyer may make any public disclosure required by applicable law, regulation
or stock market regulation (in which case the Buyer shall use reasonable efforts
to advise the Company prior to making the disclosure).

     10.2 No Third Party Beneficiaries. This Agreement shall not confer any
rights or remedies upon any person other than the Parties and their respective
successors and permitted assigns; provided, however, that the provisions in
Article I concerning issuance of the Merger Shares are intended for the benefit
of the Company Shareholders.

     10.3 Entire Agreement. This Agreement (including the documents referred to
herein) constitutes the entire agreement among the Parties and supersedes any
prior understandings, agreements or representations by or among the Parties,
written or oral, with respect to the subject matter hereof; provided that the
letter agreement dated February 2, 2000 between the Buyer and the Company shall
remain in effect in accordance with its terms.

     10.4 Succession and Assignment. This Agreement shall be binding upon and
inure to the benefit of the Parties named herein and their respective successors
and permitted assigns. No Party may assign either this Agreement or any of its
rights, interests or obligations hereunder

                                      -47-
<PAGE>

without the prior written approval of the other Parties; provided that the
Transitory Subsidiary may assign its rights, interests and obligations hereunder
to an Affiliate of the Buyer.

     10.5 Counterparts; Facsimile Signature. This Agreement may be executed in
two or more counterparts, each of which shall be deemed an original but all of
which together shall constitute one and the same instrument. This Agreement may
be executed by facsimile signature.

     10.6 Headings. The section headings contained in this Agreement are
inserted for convenience only and shall not affect in any way the meaning or
interpretation of this Agreement.

     10.7 Notices. All notices, requests, demands, claims, and other
communications hereunder shall be in writing. Any notice, request, demand, claim
or other communication hereunder shall be deemed duly delivered four business
days after it is sent by registered or certified mail, return receipt requested,
postage prepaid, or one business day after it is sent for next-day delivery via
a reputable nationwide overnight courier service, in each case to the intended
recipient as set forth below:

     If to the Company:                       Copy to:
     ------------------                       --------
     TriVida Corporation                      Fenwick & West LLP
     3524 Hayden Avenue                       Two Palo Alto Square
     Culver City, CA  90232                   Palo Alto, CA  94306
     Attn:  Mr. Alex D. Jacobson              Attn.: William R. Schreiber, Esq.
            President and CEO                 (650) 494-1417
     (310) 736-3701

     If to the Buyer or
     ------------------
     the Transitory Subsidiary:               Copy to:
     --------------------------               --------

     Be Free, Inc.                            Hale and Dorr LLP
     154 Crane Meadow Road, Suite 100         60 State Street
     Marlborough, MA  01752                   Boston, MA 02109
     Attn.:  Mr. Gordon B. Hoffstein          Attn:  Jay E. Bothwick, Esq.
             President and CEO                (617) 526-5000
     (508) 357-8880

Any Party may give any notice, request, demand, claim or other communication
hereunder using any other means (including personal delivery, expedited courier,
messenger service, telecopy, telex, ordinary mail or electronic mail), but no
such notice, request, demand, claim or other communication shall be deemed to
have been duly given unless and until it actually is received by the party for
whom it is intended. Any Party may change the address to which notices,
requests, demands, claims, and other communications hereunder are to be
delivered by giving the other Parties notice in the manner herein set forth.

                                      -48-
<PAGE>

     10.8 Governing Law. This Agreement shall be governed by and construed in
accordance with the internal laws of the Commonwealth of Massachusetts without
giving effect to any choice or conflict of law provision or rule (whether of the
Commonwealth of Massachusetts or any other jurisdiction) that would cause the
application of laws of any jurisdictions other than those of the Commonwealth of
Massachusetts.

     10.9 Amendments and Waivers. The Parties may mutually amend any provision
of this Agreement at any time prior to the Effective Time. No amendment of any
provision of this Agreement shall be valid unless the same shall be in writing
and signed by all of the Parties. No waiver of any right or remedy hereunder
shall be valid unless the same shall be in writing and signed by the Party
giving such waiver. No waiver by any Party with respect to any default,
misrepresentation or breach of warranty or covenant hereunder shall be deemed to
extend to any prior or subsequent default, misrepresentation or breach of
warranty or covenant hereunder or affect in any way any rights arising by virtue
of any prior or subsequent such occurrence.

     10.10 Severability. Any term or provision of this Agreement that is invalid
or unenforceable in any situation in any jurisdiction shall not affect the
validity or enforceability of the remaining terms and provisions hereof or the
validity or enforceability of the offending term or provision in any other
situation or in any other jurisdiction. If the final judgment of a court of
competent jurisdiction declares that any term or provision hereof is invalid or
unenforceable, the Parties agree that the court making the determination of
invalidity or unenforceability shall have the power to limit the term or
provision, to delete specific words or phrases, or to replace any invalid or
unenforceable term or provision with a term or provision that is valid and
enforceable and that comes closest to expressing the intention of the invalid or
unenforceable term or provision, and this Agreement shall be enforceable as so
modified.

     10.11 Construction.

         (a) The language used in this Agreement shall be deemed to be the
language chosen by the Parties to express their mutual intent, and no rule of
strict construction shall be applied against any Party.

         (b) Any reference to any federal, state, local or foreign statute or
law shall be deemed also to refer to all rules and regulations promulgated
thereunder, unless the context requires otherwise.

                     [THE NEXT PAGE IS THE SIGNATURE PAGE]

                                      -49-
<PAGE>

     IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date
first above written.

                         BE FREE, INC.

                         By: /s/ Gordon B. Hoffstein
                            --------------------------------

                         CYRANO ACQUISITION CORP.

                         By: /s/ Gordon B. Hoffstein
                            --------------------------------

                         TRIVIDA CORPORATION

                         By: /s/ Alex D. Jacobson
                            --------------------------------

                                      -50-

<PAGE>

                                                                      EXHIBIT 23

          We consent to the incorporation by reference in the Registration
Statements (No. 333-90859 and No. 333-90861) on Form S-8 of Be Free, Inc. of our
report dated October 15, 1999, with respect to the financial statements of
TriVida Corporation (a Development Stage Company) included in this Current
Report on Form 8-K dated March 14, 2000.

                                            /s/ Ernst & Young LLP

Los Angeles, California
March 13, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission